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Résumé Titre: La Visualisation in vivo des « espèces oxygénées  radiculaires» au 
niveau des cellules ganglionnaires de la rétine. 
Le But : Les espèces d'oxygène réactives sont non seulement produites à la suite de la 
blessure cellulaire, mais servent aussi des molécules faisantes des signes pour une variété 
de processus critiques, en incluant mitosis et de mort de cellule. Nous avons auparavant dit 
que la blessure à RGC axons incite un éclatement de superoxyde dans le corps de cellule, 
probablement de l'origine mitochondrial (Lieven et al, 2006). Nous décrivons maintenant 
une méthode pour refléter des espèces d'oxygène réactives dans la rétine de l'animal vivant 
en utilisant un confocal le lisant rapidement du laser ophthalmoscope a appelé la Rétine de 
Heidelberg Angiograph 2 (HRA2) équipé avec les lasers doubles. 
La méthodolologie : Après les études préliminaires en utilisant d'autres indicateurs 
(hydroethidium; HEt) pour les espèces d'oxygène réactives, nous avons essayé de refléter 
des espèces d'oxygène réactives dans le dans le modèle de vivo l'utilisation 5-(et 6)-
chloromethyl-2', 7 '-dichlorodihydrofluorescein diacetate, l'acétyle ester (le CM-
H2DCFDA). Un nerf optique de Longs-Evans rats a été écrasé intraorbitalement, en 
épargnant la circulation retinal. Dans certains rats colliculi supérieur de Longs rats Evans 
avait été auparavant exposé via craniotomy et surposé avec Gelfoam saturé avec le vert 
indocyanine (ICG). Aux points de temps variables les animaux ont été injectés 
intraveineusement ou intravitreally avec HEt ou le CM-H2DCFDA et reflétés avec 
fluorescein et-ou les filtres d'ICG en utilisant le HRA2. 
Les résultats: Nous avons démontré le foyer brillant multiple de fluorescence dans la 
couche de cellule de ganglion quand nous avons rétrogradement étiqueté d'ICG 
bilatéralement, en indiquant qu'ICG était un colorant rétrogradement transporté qui pourrait 
être découvert avec le HRA2. Après axotomy et l'injection intravitreal de CM-H2DCFDA, 
il y avait la fluorescence brillante dans le canal fluorescein dans quelques cellules dans la 
couche de cellule de ganglion, en accord avec la production d'une ou plusieurs espèces 
d'oxygène réactives. 
Les conclusions :  RGCs peut être identifié et les niveaux d'espèces d'oxygène réactives 
mesurés en utilisant une fréquence double confocal Mots-clés : cellules ganglionnaires de 
la rétine; especes oxygenique radiculaire; la visualisation;  
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Abstract 
Title: Imaging Reactive Oxygen Species in RGCs In vivo 
Purpose: Reactive oxygen species not only are generated as a result of cellular injury, but 
also serve as signaling molecules for a variety of critical processes, including mitosis and 
cell death. We previously reported that injury to RGC axons induces a burst of superoxide 
within the cell body, probably of mitochondrial origin (Lieven et al, 2006). We now 
describe a method for imaging of reactive oxygen species within the retina of the living 
animal using a confocal scanning laser ophthalmoscope called the Heidelberg Retina 
Angiograph 2 (HRA2) equipped with dual lasers. 
Methods: Following preliminary studies using other indicators (hydroethidium; HEt) for 
reactive oxygen species, we attempted to image reactive oxygen species in the in 
vivo model using 5-(and-6)-chloromethyl-2',7'-dichlorodihydrofluorescein diacetate, acetyl 
ester (CM-H2DCFDA). The resultant images were quantified using ImageJ. One optic 
nerve of Long-Evans rats was crushed intraorbitally, sparing the retinal circulation. In some 
rats the superior colliculi of Long-Evans rats had been previously exposed via craniotomy 
and overlaid with Gelfoam saturated with indocyanine green (ICG). At varying time points 
the animals were injected intravenously or intravitreally with HEt or CM-H2DCFDA and 
imaged with fluorescein and/or ICG filters using the HRA2. 
Results: We demonstrated multiple bright foci of fluorescence in the ganglion cell layer 
when we retrogradely labeled with ICG bilaterally, indicating that ICG was a retrogradely 
transported dye that could be detected with the HRA2. Following axotomy and intravitreal 
injection of CM-H2DCFDA, there was bright fluorescence in the fluorescein channel in a 
few cells in the ganglion cell layer, consistent with production of one or more reactive 
oxygen species. There was no cross-talk between the fluorescein and ICG channels when 
detecting ICG or CM-H2DCFDA, respectively. 
Conclusions: Retrograde labeled RGCs can be identified and levels of reactive oxygen 
species measured using a dual frequency confocal scanning laser ophthalmoscope. 
Keywords RGCs, oxidative radical, imaging  
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Introduction 1.1 Ocular anatomy 
The human eyeball is composed of the segments of two spheres of different sizes placed in 
front of the other called the anterior and the posterior poles (figure 1.1a).  
 
Figure 1.1a Diagram showing some of the structures in the mammalian eye. Courtesy 
of Dr Thomas Caceci, Virginia/Maryland Regional College of Veterinary Medicine, 
Virginia Polytechnic Institute and State University, Blackburg, Virginia, USA. 
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While we will outline the structure of the human eye, there are some subtle differences 
between this and other mammalian models which have been investigated by previous work, 
some of which we will outline during the introduction (Morrison et al 1995).  
The anterior pole of the eye is the center of curvature of the transparent segment or cornea, 
which is involved in refracting or directing light rays through the anterior portion of the eye 
before light travels back through the lens and is focused on the retina. The posterior pole is 
the center of the posterior curvature of the eyeball and this is located slightly temporal to 
the optic nerve.  
The sclera forms the posterior five-sixths of the eyeball and appears white to opaque in 
color. This fibrocollagenous structure gives the eyeball its shape and deformability and 
provides a degree of protection for the less robust, delicate structures located within the 
eyeball.  
As the cornea is a structure which will be important to the study, we will briefly outline its 
anatomy in more detail. The cornea is a transparent multilayered transparent structure 
forming the anterior one-sixth of the eyeball. The layers from inside to out are as follows: 
the epithelial layer, Bowmans membrane, substantia propria, descements membrane and 
endothelium. The epithelial layer is stratified and consists of five layers of cells, ranging 
from the superficial flattened, nucleated, nonkeratinized squamous cells to the deeper cells 
which are more columnar in shape. The deepest columnar cells form a single layer and rest 
on a basement membrane. The columnar cells lateral borders interdigitate with each other 
and are attached by desmosomes and gap junctions while hemidesmosomes attach to the 
underlying Bowmans layer. Bowmans layer lies immediately beneath the basement 
membrane of the corneal epithelium and is acellular, consisting of interwoven collagen 
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fibrils embedded in intercellular substances. The stroma forms approximately 90% of the 
corneal thickness and is composed of lamellae of collagen fibrils that run in parallel with 
the surface which are embedded in glycosaminoglycans with occasional macrophages, 
lymphocytes and polymorphonuclear leukocytes. Descements membrane lies on the 
posterior surface of the stroma and is the basement membrane of the endothelium. It 
consists of collagen fibrils arranged in a hexagonal pattern and embedded in matrix. At the 
corneal margin the membrane terminates abruptly and becomes continuous with the 
trabecular tissue. The anterior border of the trabecular meshwork is known as the line of 
Schwalbe. The corneal endothelium consists of a single layer of flattened cells which are 
polygonal in shape and whose plasma membrane interdigitate with each other and are 
connected via tight junctions.  
 
The limbus (corneoscleral junction) is an important landmark in our study and we will 
briefly outline its structure and importance (figure 1.1b).  
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Figure 1.1b Section through anterior portion of eye showing limbal structures.  
Courtesy of Dr Thomas Caceci, Virginia/Maryland Regional College of Veterinary 
Medicine, Virginia Polytechnic Institute and State University, Blackburg, Virginia, 
USA. 
 
Previous studies in humans have demonstrated the limbus to be approximately 1.5 to 2.0 
mm wide in the human model (Patel et al 2006) although there is a dearth in the literature 
of similar anatomical studies in the rat model or other mammalian models regarding its 
exact size and dimensions. The inner surface of this structure contains the trabecular 
meshwork and the canal of Schlemm. The aqueous fluid of the eye is produced in the 
trabecular meshwork while the canal of Schlemm serves to transport this fluid from the 
anterior chamber. Increased resistance to outflow of the aqueous fluid through the 
trabecular meshwork into the canal of Schlemm causes the condition known as glaucoma in 
which the intraocular pressure is often raised and atrophy of the optic nerve occurs. The 
limbus is an important landmark, particularly in our future experiments. It is the site where 
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the cornea and sclera merge with each other. The anatomic limbus is defined by 
Schwalbes line while the surgical limbus id defined by the beginning of the bluish area 
marking the transition zone between the cornea and the sclera. The surgical limbus is 
located slightly anterior to the anatomic limbus and is the entry point for virtually all types 
of anterior segment surgery and intravitreal injections in the human and mammalian 
models.  
 
 
Figure 1.1c Diagram showing structures in the region of the corneoscleral junction.  
Image courtesy of Dr Thomas Caceci, Virginia/Maryland Regional College of 
Veterinary Medicine, Virginia Polytechnic Institute and State University, Blackburg, 
Virginia, USA. 
 
Posteriorly, the optic nerve exits the eye at the optic disc whose anatomical course will be 
discussed in greater detail in the next section.  
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Physiological concerns in rodents were also pertinent to this project. Previous studies had 
examined methods used to calculate the intravascular volume in adult rats (Belcher et al 
1957). There have been few publications with regard to this in the literature with Belcher et 
al providing the most comprehensive review of this topic. Using this as a guide we were 
able to calculate the most appropriate volumes to inject intravascularly and intravitreally.          
 
Histology of the retinal ganglion and retina 
RGC bodies represent the output of the retina (see figure 1.1a). Their soma (bodies) are 
located in the retina while their axons extend as far as the lateral geniculate body where 
they synapse. Ganglion cells fire action potentials and have a negative resting potential of  
approximately – 70 mV. At this resting potential there is a tension between the 
concentrations and charges of sodium and potassium inside and outside the neuron. When 
ganglion cells receieve a suprathreshold level of input from the bipolar cells, voltage-gated 
sodium channels open and Na+ ions rush in along the concentration gradient. This causes a 
sudden reversal of the charge from negative to positive and this propogates down the body 
(axon) of the neuron. Finally the potassium channels open, which restores the cell to its 
negative resting potential. The refractory period of the RGC is defined as the time after a 
neuron has fired an action potential during which it cannot fire another. The firing rate of 
the neuron (e.g., spikes per second) is what represents information about stimulus intensity 
within each neuron. 
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Figure 1.1f above shows the annotated layers of the retina in a retinal cross section 
with the actual cells in the schematic on the right. Courtesy of Dr David Van Essen, 
Department of Anatomy and Neurobiology, Washington University in St Louis School 
of Medicine.  
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Figure 1.1g below shows retinal layers in a mouse model 
Image showing layers of the retina. Image courtesy of Dr Thomas Caceci, The 
Virigina-Maryland Regional college of Vetrinary Medicine.  
  
RGCs fire action potentials in response to certain types of retinal stimulation. The 
pioneering work by Hubel and Weisel marked the earliest attempted by researchers to 
characterize their receptive fields (Hubel et al 1977). The receptive field is defined as the 
part of the retina that needs to be stimulated in order to elicit a spike.It is the part of the 
visual world that the neuron is responsive to (that it "sees") or what the visual stimulus 
needs to be in order to elicit spikes.  
 
Most RGCs have concentric (or center-surround) receptive fields. These receptive fields are 
divided into 2 parts (center/surround), one of which is excitatory ("ON"), the other 
inhibitory ("OFF"). For an ON/OFF center/surround cell, a spot of light shown on the 
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inside (center) of the receptive field will elicit spikes, while light falling on the outside 
ring (surround) will suppress firing below the baseline rate.  
 
Visual neurons do not simply "pipe" the output of the retina through the visual pathways. 
Instead, the activity of a given neuron is affected by the activity of nearby neurons. Lateral 
inhibition in the RGCs is a prime example. When a RGC fires action potentials, it also 
inhibits the firing of nearby (lateral) ganglion cells. Lateral inhibition performs edge 
(contrast) enhancement. 
RGCs are located in the inner portion of the retina (figure 1.1f) and these cells are 
concerned with conveying visual information from the retina along the visual pathway.  
The human retina is approximately 0.2 mm thick with an area of approximately 1100 mm2.  
As the below diagram of the retina shows, it is composed of 10 layers. In order to better 
understand the background to our project, it is necessary to have a knowledge of the 
anatomy and histology of the retina. The inner limiting membrane (ILM) marks the 
boundary between the vitreous humor in the posterior chamber and the retina itself. Which 
is the most anterior portion of the retinal layers.  
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Figure 1.1 H Image showing the layers of the retina. 
Image courtesy of Dr Thomas Caceci, The Virgina-Maryland Regional college of 
Vetrinary Medicine.  
 
The ganglion cell layer is comprised of the cell bodies and the axons of the ganglion cells 
as well as displaced amacrine cells. The inner plexiform later (IPL) contains synapses made 
between bipolar, amacrine and ganglion cells, its thickness varying depending on the 
animal concerned with higher order primates having thinker retina and consequently more 
developed peripheral and specialized image processing.  
The inner nuclear layer (INL) contains bipolar cells, horizontal and amacrine cell bodies.  
The outer plexiform layer (OPL) contains a network of synapses between the dendrites of 
horizontal cells from the inner nuclear layer and the photoreceptor cell inner segments from 
the outer nuclear layer. The outer limiting membrane coincides with the base of the inner 
segments of photoreceptors. The photoreceptor layer contains inner and outer segments of 
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rod and cone photoreceptors.  
Pigment epithelium contains darkly pigmented cells responsible for absorbing light not 
captured by photoreceptors and therefore reducing scattering. In our project we are 
primarily concerned with RGCs.   
 
Anatomy of the visual pathway  
In the human model, the optic nerve is divided into intraocular (1 mm), intraorbital (25 
mm), intracanalicaular (5 mm) and intracranial (10 mm) segments. 
 
The intraocular portion  includes the optic disc and the portion of the optic nerve that lies 
within the sclera. The optic disc is generally approximately 1.5 mm in diameter and marks 
the point at which the axons of the RGCs converge before exiting. It has a pink colour and 
is paler than the surrounding retina with a flat or slightly raised edge and a central slight 
depression. The axons of the RGCs located in the peripheral retina take up a peripheral 
position and those from the central retina take up a more central position in the optic nerve. 
As the RGCs axons bend sharply posteriorly at the disc, they are unmyelinated and 
supported by astrocytes and at the periphery of the disc are covered by the internal limiting 
membrane of the retina.  
The orbital portion of the optic nerve crosses the lamina cribrose which the portion of the 
bone resembling a sieve and acquire a myelin sheath which are formed by 
oligodendrocytes. Outside this is a dense sheath of dura mater, a middle delicate sheath of 
arachnoid and an innermost vascular sheath of pia mater. Posteriorly the sclera and sheaths 
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blend together and the sheaths are continuous through the optic canal with the meningeal 
coverings of the brain.  
The optic nerve is surrounded by orbital fat and within this are the ciliary vessels and 
nerves. The ciliary ganglion lies between the lateral border of the nerve and the lateral 
rectus muscle. Posteriorly the nasociliary nerve and the ophthalmic artery run forward and 
pass medially to cross the optic nerve. At about the same position, the nerve to the medical 
rectus muscle from the inferior division of the oculomotor nerve crosses below the optic 
nerve.  At about the same position the nerve to the medial rectus muscle from the inferior 
division of the oculomotor nerve crosses below the optic nerve. At approximately 12 mm 
behind the eyeball, the inferomedical dural sheath surface is pierced by the central retinal 
artery and vein of the retina. The artery crosses the subarachnoid space obliquely before 
entering the optic nerve. The vein has a more prolonged course in the subarachnoid space 
and lies posterior to the artery. The central vessels assume an axial position and pass 
forward to emerge on the optic disc. At the apex of the orbital cavity, the optic nerve lies 
within the muscular cone formed by the four recti and is surrounded by their tendinous 
origins. The optic nerve axons are grouped together into bundles separated by fine septa 
derived from the inner surface of the pial sheath.  
In the intracanalicular portion of the optic nerve, the optic canal lies within the lesser wing 
of the sphenoid bone and is about 5 mm long. The optic nerve passes through the optic 
canal surrounded by its three meningeal coverings (dura mater, pia mater, arachnoid mater). 
The subarachnoid space is filled with cerebrospinal fluid around the optic nerve, 
communicates and is discontinuous with the intracranial subarachnoid space. Also passing 
through the optic canal are the ophthalmic artery on the infero-lateral border of the optic 
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nerve and the postganglionic sympathetic nerves accompanying the artery.  
 
The intracranial portion is 10 mm in length and begins as the optic nerve leaves the canal 
and passes backward, upward and medially within the subarachnoid space and reaches the 
optic chiasm which is located in the floor of the third ventricle.  The optic nerve is  
ocomposed of 1,200,000 myelinated axons and about 90% of these are of small diameter (1 
µm) and the remainder measure from 2 to 10 µm in diameter.  
The optic chiasm is situated at the junction of the anterior wall and floor of the third 
ventricle. It is composed of a flattened bundle of nerve fibers with dimensions of 12 mm 
wide and 8 mm from anterior to posterior. The chiasm is covered with pia mater and 
projects downward into subarachnoid space. In the human chiasm the nerve fibers from the 
nasal half of the retina cross the midline and enter the optic tract of the opposite side ; the 
nerve fibers from the inferior nasal retina cross at the anterior part of the chiasm, whereas 
the nerve fibers from the superior nasal retina cross at the posterior part of the chiasm. The 
nerve fibers from the temporal half of the retina pass backward into the optic tract of the 
same side. The partial crossing of the optic nerve fibers in the optic chiasm is essential for 
binocular vision.  
The optic tracts emerge from the posterolateral angles of the optic chiasma as a cylindrical 
band. Each passes posterolaterally between the tuber cinereum medically and the anterior 
perforated substance laterally. The tract becomes flattened and and winds around the lateral 
margin of the upper part of the cerebral peduncle, adherent to midbrain and overlapped by 
the uncus and the parahippocampal gyrus. In the human most of the nerve fibers in the 
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optic tract terminate in the lateral geniculate body and are concerned with conscious 
visual sensations; these fibers constitute the lateral root of the optic tract. The smaller 
medial root contains fibers which are of unknown function. Priot to its entry into the lateral 
geniculate nucleus, about 10% of fibers pass medially in the superior brachium below the 
pulvinar of the thalamus to enter the superior colliculus and the pretectal nucleus.  These 
fibers are involved in visual body reflexes and light reflexes respectively (Shernab et al 
1982).  
 
Lateral geniculate body  
The lateral geniculate body is a small ovoid swelling on the undersurface of the pulvinar of 
the thalamus which is connected by the superior brachium which is formed by the nerve 
fibers that do not terminate in the lateral geniculate body but pass to the superior colliculus 
and pretectal nucleus as described above. The dorsal or main lateral geniculate nucleus has 
a laminated structure and consists of six curved layers of cells oriented in a dome-shaped 
mound, often likened to a stack of hats on top of one another. These layers of cells are 
separated by white bands of optic nerve fibers and are numbered 1 to 6 beginning at the 
hilus and continuing dorsally to the crest of the geniculate body. The nerve fibers are the 
axons of the ganglion cell layer of the retina and come from the temporal half of ipsilateral 
eye and from the nasal half of the contralateral eye, the latter fibers crossing the midline in 
the optic chiasm. The nerve fibers that cross the midline terminate in layers 1, 4 and 6 while 
the optic nerve fibers that do not cross terminate in layers 2, 3 and 5. The peripheral retinal 
fibers end in the anterior part and the upper retinal quadrants end medially and the lower 
ones laterally. The macular fibers end in the center and posterior part of the nucleus. Each 
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lateral geniculate body receives information from both retina.    
 
Optic radiations  
The optic radiations or geniculocalcarine tracts are formed of nerve fibers that originate 
from the nerve cells in the laminae of the lateral geniculate bodies. Fibers originating from 
the lateral portions of the lateral geniculate body receive fibers from the inferior retinal 
quadrants (superior visual field) fan out laterally and inferiorly around the anterior tip of the 
inferior (temporal) horn of the lateral ventricle, before swinging posteriorly. The fibers 
associated with the peripheral part of the retina swing farthest forward and those related to 
the macula loop very little. These forward looping fibers form the loop of Meyer. The 
fibers continue posteriorly in the retrolentiform part of the internal capsule, lying lateral to 
the inferior (temporal) and posterior (occipital) horns of the lateral ventricle. They 
terminate by turning medially to enter the occipital cortex. Here, the fibers end on the 
inferior lip of the calcarine fissure.  
 
Fibers originating from the medial portions of the lateral geniculate body receive impulses 
from the superior retinal quadrants (inferior visual field) and turn directly posteriorly and 
accompany the other fibers in the retrolentiform part of the internal capsule. On entering 
the occipital cortex, the fibers terminate in the superior lip of the calcarine fissure.   
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Visual cortical areas  
 The primary visual area (area 17) occupies the walls of the deep calcarine sulcus on the 
medial surface of the hemisphere and extends onto the cortex superior and inferior to 
sulcus. Posteriorly it extends as far as the occipital pole and a small portion of variable size 
extends forward above the calcarine sulcus as far as the parieto-occipito sulcus; below the 
calcarine sulcus, it extends forwards a little further.  
Grossly on sections, the primary visual cortex can be recognized by its thinness and the 
characteristic presence of a white line or stria (of Gennari) in the gray matter . This white 
line is formed by the fourth layer of the cortex by the presence of myelinated fibers 
emanating from the optic radiation and association fibers.  
Histologically the visual cortex is of the granular type with only a few pyramidal cells 
being present. Although the cortex is thinner (1.5 mm) than other cortical regions, the cell 
population is greater and the intercellular spaces are reduced compared with other cortical 
regions. The primary visual cortex has six layers. The cells in laminae II and III project to 
the secondary visual area (areas 18 and 19). The cells of laminae V project to the superior 
colliculus; those of lamina VI to the lateral geniculate body.  The cortex receives fibers 
from the temporal half of the ipsilateral retina and the nasal half of the contralateral retina. 
The right half of the field of vision is represented in the visual cortex of the left cerebral 
hemisphere and vice versa. The superior retinal quadrants (inferior field of vision) pass to 
the superior wall of the calcarine sulcus, while the inferior retinal quadrants (superior field 
of vision) pass to the inferior wall of the calcarine sulcus. The macula lutea which is the 
central part of the retina and the area for most acute vision is represented on the cortex in 
the posterior part of the area 17 and accounts for one third of the visual cortex. The 
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peripheral parts of the retina are represented more anteriorly (Alexander et al 1986).   
The secondary visual areas are also known as areas 18 and 19 and surround the  primary 
visual areas on the medial and lateral surfaces of the hemisphere. These areas are nonstriate 
and histologically show the usual six layers. The secondary association areas receive 
afferent fibers from the primary visual cortex and other cortical areas as well as the 
thalamus. The secondary visual areas have a role to play in relating the visual information 
received by the primary visual area to past visual experience, thus enabling the individual 
to recognize and appreciate what one is doing. In addition to this, area 18 also integrates the 
two halves of the visual fields by means of commisural fibers that cross the midline in the 
splenium of the corpus callosum. It is possible that area 18 is involved in sensory motor eye 
coordination and is linked to the frontal eye field. The frontal eye field is the area anterior 
to the facial area of the precentral gyrus extending into the middle frontal gyrus  
(Brodmann areas 6, 8 and 9). Area 18 may also be linked by descending pathways to the 
cranial nerve nuclei controlling the extraocular muscles and thought to be involved in 
smooth pursuit of visual targets (Ts'o et al 1988, Bosking et al 1997, Van Essen et al 1992, 
LeVay et al 1980, Livingstone et al 1988, Halder et al 1995).     
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1.2 Retinal ganglion cell death 
Our study focuses primarily on the imaging of reactive oxygen species in RGCs undergoing 
axonal injury. Therefore a brief introduction is included on the mechanisms of retinal 
ganglion cell death. There are a myriad of proposed mechanisms involved in retinal 
ganglion cell death, however the focus here will be on a small number of these.   
All optic neuropathies cause retinal ganglion cell death. The initial site of injury in one type 
of optic neuropathy i.e. glaucoma, is in the RGC axons within the optic nerve. RGC axons 
are vulnerable as they pass through the sieve-like lamina cribrosa and elevated IOP as in 
glaucoma can cause distortion and compression of RGC axons leading to ischemia, hypoxia 
and deprivation of neurotrophic factors. In other diseases of the optic nerve, the intraocular 
pressure is normal and RGC death and subsequent loss of vision continues to occur. 
Although there are many proposed mechanisms, the exact etiology behind RGC death in 
these circumstances remains unknown.  
 
During development neurons are eliminated by the intrinsic process of apoptosis and only 
those which secrete neurotropic factors escape death. It is proposed that in developing 
RGCs, deprivation of BDNF and NGF leads to cell death. It is not yet established whether 
this occurs in the adult RGC maintenance and could perhaps be a factor in disease where 
axonal transport is disrupted (Pease et al 2000). The actions of neurotrophins are mediated 
by two principal transmembrane-receptor signaling systems. Each neurotrophin receptor — 
TrkA, TrkB, TrkC and the p75 neurotrophin receptor (p75NTR) — is characterized by 
specific affinities for the neurotrophins nerve growth factor (NGF), brain-derived 
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neurotrophic factor (BDNF), neurotrophin 3 (NT3) and NT4. An emerging concept is 
that the two distinct receptor classes, Trk and p75NTR, preferentially bind mature and 
proneurotrophins (neurotrophin precursors), respectively, to elicit opposing biological 
responses. LTD, long-term depression; LTP, long-term potentiation. 
We know from previous work that apoptosis plays a central role in optic neuropathies 
(Murphy et al 2006). Although there are many proposed mechanisms this brief discussion 
will focus on three main parts to this pathway: the BCL-2 protein family (whose expression 
has already been shown in the retina by Levin et al), the caspase pathway and the calcium -
dependent pathways.  
The BCL-2 protein family is especially important in glaucoma. Several BCL-2 pathways in 
mammals and many inhibit apoptosis(bcl-2 bcl-x) and others promote it (Bad, Bax, Bid). 
One mechanism of action involves either promoting or preventing cytochrome c release 
from mitochondria.  
Recent Bax deficient mice showed preserved RGCs indicating that is required for survival. 
The caspase pathway is also proposed to be involved in executing RGC death, broadly 
speaking caspases 1, 2, 4, 5, 8, 9, 10 are inhibitors and 3, 6, 7, and 14 are effectors. 
Calcium dependant pathways are very important in the apoptotic process. High intraaxonal 
or intracellular levels of calcium are toxic and calcium enters the cell in three ways: the 
voltage-gated calcium channels, store-operated channels, receptor-gated channels. Within 
the cell, calcium is sequestered by mitochondria, ER and calcium-binding proteins.  
Calcium-induced apoptosis depends on calcineurin, a calcium-dependant phosphatase. 
Calcicneurin can dephosphorylate the proapoptotic BAD protein. BAD can then translocate 
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from cytoplasm to mitochondria where it can bind BCL2 or BCL-XL . Formation of these 
protein complexes leads to increased permeability of the mitochondrial cell membrane, 
cytochrome C release and neuronal apoptosis.  
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1.3 Retinal ganglion cell death models  
Despite its unique location described previously, the optic nerve is a central nervous system 
white matter tract. Therefore, injury to the mammalian RGC axon results in death of the 
cell body, and an inability of the axon to regenerate. The precise timing of this process 
remains unknown. Understanding how to prevent this irreversible loss of RGCs is 
important in finding new therapies for optic neuropathies.  
There are several models used for the study of RGC death in the live (in vivo) animal 
model including mouse, murine, bovine, feline, canine, rat and monkey. Each of these has 
varying similarity to the human model. Although we cannot directly extrapolate findings 
from animal models to the human model, they allow us to study RGC death in a relatively 
similar environment. Previous studies have shown that the morphological changes at the 
primate optic nerve head are similar to that seen in human patients with glaucoma, although 
the course of the disease is much more rapid, taking place over months. Primates can be 
difficult to study in large numbers and in order to overcome this obstacle, models have been 
devised for rodent models. In the rat, the limbal and episcleral veins can be occluded by 
cautery (Garcia-Valenzuela et al 1995), sclerosis with hypertonic saline (Morrison et al 
1997), or argon laser (Schori et al 2001). In view of the applicability and robustness of the 
rodent model, we choose the rat as our model to study the generation of reactive oxygen 
species following RGC damage (Shen et al 1999).  
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A well-established method for causing axonal damage and enabling study of the resultant 
effects on the RGC is directly damaging the optic nerve. The injury used is typically acute, 
although graded injuries have been designed to more closely mimic the chronic nature of 
some diseases. Most of these models are done with rodents, more commonly rats because 
of difficulty in surgical exposure and a tendency to bleed in the mouse or rat. The most 
common model for optic nerve injury is in rodents, either rats or mice, and uses either optic 
nerve transection (e.g. crush) or experimental glaucoma (raising the eye pressure). Rodents 
allow us to study RGCs, which closely resemble those in the human eye. These models are 
universally used in virtually every laboratory in the world studying optic nerve disease 
(Berkelaar  et al 1994, Bertrand et al 2007, Freeman et al 2000, Lebrun-Julien et al 2009, 
Li et al 1999, Lieven et al 2006, Schlamp et al 2001, Swanson et al 2005). There has been 
extensive use of rats in ophthalmology research in this and other facilities with the 
techniques which we will use already well established in the literature (Berkelaar  et al 
1994, Freeman et al 2000, Li et al 1999, Schlamp et al 2001, Swanson et al 2005, Lieven et 
al 2006).  
The actual injury can be obtained by either crushing or transecting the optic nerve 
(Morrison et al 1997). Crushing the optic nerve, if done carefully, can preserve circulation 
to the retina, but careful post-operative ophthalmoscopy using either a direct or indirect 
ophthalmoscope is necessary to exclude infarction. 
To eliminate the potential for disturbing the retinal blood supply, the optic nerve can be 
transected via an intracranial approach. This approach avoids the blood vessels that supply 
the retina directly. However, this technique also involves aspiration of part of the overlying 
cortex to gain access to the intracranial optic nerve, which might have other effects on the 
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animal. Other techniques described in the literature have used a lateral approach from the 
temporal aspect of the orbit and in this way result in less damage to the surrounding orbital 
structures and cortex. It is for this reason that the technique we will use in our study will 
involve the lateral approach to the optic nerve.  
 
Partial crush injuries of the optic nerve have been used to produce graded optic nerve loss. 
This technique results in the continuous loss of fibers when studied at time points days or 
even weeks after the initial injury (Yoles et al 1997). This further loss after the primary 
insult has been named secondary degeneration, similar to what is seen with other injuries 
within the central nervous system. The mechanism by which this occurs has been 
hypothesized to be due to excitotoxicity within the retina. Another technique described in 
the literature has described using an inflatable balloon against the optic nerve within the 
orbit in feline models to induce chronic optic nerve compression (Lu et al 2006, Clifford-
Jones et al 1985). However, this primarily induces demyelination and relatively less axonal 
injury (Gellrich et al 2002). 
 
Optic nerve head ischemia can be used to model the potential role of blood flow reduction 
in glaucoma. This spans several models already established in the literature. The blood 
supply to the optic nerve head can be interrupted by occluding the posterior ciliary 
circulation originally described in the 1970s (Levy et al 1976). In the monkey this can be 
done under direct observation. In the rat model, the meninges can be separated from the 
nerve and compressed with a ligature, interrupting the blood supply to the optic nerve head. 
However, this will also interrupt the blood supply to the central retinal artery. Infusion of 
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endothelin-1, a potent vasoconstrictor, into the subarachnoid space around the optic 
nerve of rabbits or primates can be used to induce optic nerve head ischemia, and therefore 
also injure optic nerve axons indirectly (Tezel et al 2000). This has the advantage that the 
injury is relatively chronic (weeks), unlike the acute injuries associated with ligating blood 
vessels. Acutely elevating the intraocular pressure above the systolic blood pressure will 
cause retinal hypoperfusion, and if sustained, will infarct RGCs, indirectly causing an optic 
neuropathy. Several novel mechanisms have also been more recently described in the 
literature including the photoembolic technique used in primates (Chen et al 2008) 
 
RGC excitotoxicity has been extensively studied in the literature in various animal models 
(Yucel et al 2005, Hare et al 2004, Schori et al 2001, Woldemussie et al 2002). It has 
already been established from these and other studies that RGCs are very susceptible to the 
toxic effects of the excitatory amino acid transmitter glutamate. This excitotoxicity is 
mediated by N-methyl-D-aspartate (NMDA) receptors. There also is a role for non-NMDA 
receptors in glutamate excitotoxicity of RGCs. Glutamate, NMDA, or other excitotoxic 
compounds can be injected intravitreally in the experimental animal and have been shown 
to cause loss of RGCs. Some animal studies have even examined the potential use of a 
vaccine in mice which mitigates against the excitotoxic effects of glutamate (Schori et al 
2001). In the neonatal animal these agents can be given systemically. Systemic glutamate 
does not have a significant effect in the adult animal as it does not cross the blood-retinal 
barrier. 
Methanol  is clinically associated with a toxic optic neuropathy, and has been used in 
animal models to induce an experimental optic neuropathy. In the rat model there are potent 
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mechanisms for the prevention of methanol toxicity via the oxidation of its toxic 
metabolite formate. This can be blocked by the co-administration of nitrous oxide, allowing 
the formate levels to increase to toxic levels, inhibit mitochondrial cytochrome oxidase, and 
induce an optic neuropathy and a retinal injury, i.e. a mixed neural injury (Murray et al 
1991).   
 
 
1.4 RGC Labeling  
Techniques available for labeling RGCs  
Currently there are several available methods for labeling of RGCs in both the in vitro and 
the in vivo model. Currently there are several methods available for imaging mammalian 
neurons in a time-lapse fashion in the live animal in the peripheral nervous system (Walsh 
et al 2003) and in the brain (Vercelli et al 2000, Grutzendler et al 2002, Trachtenberg et al 
2002). In the retina the periodic imaging of the retina and its dendritic processes has been 
possible in the living zebra fish (Munn et al 2006, Zoloessi et al 2006). In the mammalian 
model RGCs have been imaged in the live animal using various techniques (Codeiro et al 
2004, Engelmann et al 1999, Gray et al 2008, Higashide et al 2006, Sabel et al 1997, 
Schmitz-Valckenberg et al 2008, Seeliger et al 2005, Thanos et al 2002). For technical 
reasons, in vivo imaging of individual RGCs and their dendric arbors which require even 
higher resolution to image, have not been previously possible in mammals (Chalupa et al 
2006, Morgan et al 2005) 
The retrograde labeling technique for RGCs has been cited extensively in the literature in 
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which a fluorescent dye is either injected into the superior colliculis or the area is 
overlaid with a piece of gelfoam soaked in the required fluorescent probe. Retrograde 
markers in which the dye is transported using the intrinsic retrograde transport mechanism 
of cells include dyes such as fluorogold, fast blue, cascade blue, latex nanospheres, cascade 
blue, lucifer yellow, diamidino yellow and hydroxystilbamidine methanesulfonate. Dynein, 
a motor protein responsible for retrograde axonal transport, carries vesicles and other 
cellular products toward the cell bodies of neurons. Its light chains bind the cargo and its 
globular head regions bind the microtubule, “inching” along it. Retrograde transport 
medicated by dynein sends chemical messages and endocytosis products traveling towards 
endolysosomes from the axon back to the cell. Fast retrograde transport can cover 100 to 
200 millimeters per day (Otas et al 2003, Sabry et al 1995, Karp et al 2005, Brown et al 
2003, Roy et al 2007).  
Anterograde tracers perclude those which hitchhike on the axons intrinsic anterograde 
transportation mechanism include those such as dextran conjugates, Pha-L, Biocytin. 
Bidirectional transportation systems which utilise both antergrade and retrograde 
transportation mechanisms include markers such as DiI and DiO 
 
Other groups have outlined the use of ICG, which is a tricarbocyanine dye and can be used 
as a a RGC marker in the rat model using the well-described retrograde labeling technique. 
This dye has an axonal transport rate of 2 mm per hour and persistence of this for between 
7 to 14 day and its appearance in the RGCs seen within 4 hours of injection into the lateral 
geniculate nucleus (Paques et al 2003). These features make it an important novel method 
of marking RGCs.  
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The dialkylcarbocyanines have spectral properties that are largely independent of the 
length of the alkyl chains, and are instead determined by heteroatoms in the terminal ring 
systems and the length of the connecting bridge. They have extremely high extinction 
coefficients, moderate fluorescence quantum yieldsand short excited state lifetimes in lipid 
environments. Despite this, their fluorescence is easily detected when incorporated into 
membranes. There are several in existence including DiI, DiO, DiA and DiR.     
In an attempt to seek a less invasive method of labeling RGCs, several researchers have 
published techniques using members of the fluorescent protein family to label RGCs. The 
family of fluorescent proteins encompasses several proteins having the distinctive B-
pleated sheet structure of fluorescent proteins. The cell surface glycoprotein known as Thy-
1 is expressed by projection neurons in many parts of the nervous system and in the retina 
is largely expressed in RGCs. In the transgenic mouse model developed by Feng (Feng et 
al 2000), the fluorescent protein is under the control of the Thy-1 promoter construct 
protein. One paper examined mice in which cyan fluorescent protein was expressed in 
RGCs and used DiI as the confirmatory marker for RGCs. This represented a less invasive 
mechanism for labeling RGCs in the live animal and utilised the confocal scanning laser 
ophthalmoscope to image the RGCs (Leung et al 2008). Another more recent paper utilized 
a similar technique except this time used mice which had yellow fluorescent protein 
expression (Walsh et al 2008).  
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1.5 Detecting reactive oxygen species 
There are several labeling markers available on the market for indicating the presence of 
reactive oxygen species. These include the non-specific markers of reactive oxygen species 
as well as the more specific markers which label individual reactive oxygen species.   
Non-specific markers of reactive oxygen species  
5-(and-6)-carboxy-2’,7’-dichlorodihydrofluorescein diacetate (CM -H2DCFDA)  
Non specfic markers of reative oxygen species include CM-H2DCFDA, known by its 
chemical name as 2,7-dichlorodihydrofluorescein diacetate. Upon passive entry into the 
RGC, CM-H2DCFDA undergoes deacetylation by non-specific cell esterases forming the 
product 2,7–dichlorodihydrofluorescein. Following reaction with certain intracellular 
reactive oxygen species (peroxyl, alkoxyl,, carbonate and hydroxyl radicals and 
peroxynitrite) it forms an intermediate radical and then finally the fluorescent product 
called 2, 7- dichlorofluorescein (Le Bel et al 1992, Ischiropoulos et al 1999, Bilski et al 
2002, Ohashi et al 2002, Wardman et al 2002, Myhre et al 2003). This final product of 
oxidation has an excitation maximum of 488 nm and an emission maximum of 525 nm.    
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Figure 1.5 A showing the various products produced by 2, 7,- 
dichlorodihydrofluorescein.  
 
CMH2DCFDA has a very low reactivity towards some other reactive oxygen species such 
superoxide radicals or its dismutation product, hydrogen peroxide.   
Superoxide anion 
Dihydrorhodamine (RhH2) forms fluorescent rhodamine in the presence of free ·OH- or 
CO3· - or NO2·  radicals, while similarly to DCFH2 is unreactive with O2·  – or H2O2 in the 
absence of catalyst (Crow et al 1997, Wrona et al 2005).  
Dihydroethidium (also known as hydroethidine) can be used to analyze the presence of 
superoxide anion (Fink et al 2004, Zhao et al 2003, Zhao et al 2005). Although not 
specific, it is much more reactive than the dihydrofluoresceins or dihydrorhodamines. 
Dihydroethidium has an excitation and emission spectrum of 488 nm and 550 nm 
respectively. Once oxidized to ethidium, it can intercalate with the cells nuclear DNA to 
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form oxy-ethidium-DNA and undergo a shift in its excitation/absorption spectra.  
Although somewhat specific for the superoxide anion, dihydroethidium is readily oxidized 
and often gives a high background fluorescence (Bruxer et al 1999, Zhao et al 2003). It can 
also undergo a direct redox reaction with ferricytochrome c. It has been used to analyze 
respiratory burst in respiratory phagocytes as well as the generation of the superoxide anion 
in previous in-vitro studies using the RGC-5 cell line (Lieven et al 2006).  
 
 
 
 
 
 
 
 
 
Mitochondrial superoxide levels can be detected using MitoSOX Red mitochondrial 
superoxide indicator. This is a highly selective dye for the detection of superoxide in 
mitochondrial live cells. It is a live-cell permeant and is rapidly and selectively targeted to 
the mitochondria and once inside is oxidised and exhibits red fluorescence upon binding to 
nucleic acids (excitation/emission, 510/ 580 nm).  
 
Lucigenin, bis-N-methylacridinium dinitrate has been widely studied as an indicator of 
superoxide anion production. Despite this there is little doubt that like CM-H2DCFDA, it is 
Figure 1.5 B Structures of ethidium bromide, dihydroethidium and 
related pathways of conversion to its byproducts are shown below.  
 
   Ethidium Bromide            Dihydroethidium 
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also capable of detecting superoxide anion. After the addition of superoxide to the free 
radical obtained on the reduction of lucigenin (LC·-), which forms an unstable product 
called dioxetane (Faulkner et al 1993). The dioxetane cleaves spontaneously to produce N-
methylacridone in an excited state and it is this which emits light. Numerous nucleophiles 
and reducing agents can induce luminescence (Maskiewicz et al 1978, Maskiewicz et al 
1978).  
Hydrogen peroxide. Hydroperoxide, peroxyl radicals 
The Amplex Red peroxide/peroxidase assay provides a one-step assay for detecting 
hydrogen peroxide or the activity of horseradish peroxidase by either measuring 
fluorescence with a fluorescence-based microplate reader or a fluorometer or by measuring 
absorption- based microplate reader or spectrophotometer. The Amplex Red peroxidase 
substrate can detect the presence of active peroxidases and the release of hydrogen peroxide 
produced as a product of enzyme-coupled reactions.  
For the detection of peroxyl radicals an assay which utilizes BIODIPY dyes is available. 
This is based on the loss or shift of the dye’s fluorescence as a result of its interaction with 
the peroxyl radicals and on the retention of the fluorescent signal in the presence of 
antioxidants that intercept these free radicals. The assay is suitable for a fluorescence 
microplate reader and radiometric measurements are made with either a fluorescence 
microplate reader or flow cytometer. Peroxyl radicals can also be detected in erythrocyte or 
red blood cell membranes using a water-soluble BIODIPY dye or BIODIPY FL 
hexadecanoic acid. This exhibits the red shift common to the fluorescence of lipophilic 
BIODIPY dyes when they are concentrated, permitting the radiometric measurement of 
hydroxyl radical production as well as allowing the onset of lipid peroxidation in live cells 
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to be measured.  
 
Hydroxyl radicals 
Hydroxyl radicals can be detected following reaction with spin traps. An example of this is 
proxyl fluorescamine. This contains a nitroxide moiety that effectively quenches its 
fluorescence. Once it traps a hydroxyl radical, its fluorescence is restored and the radicals 
electron spin resonance signal is destroyed, making these probes useful for detecting 
radicals either by fluorescence or by electron spin resonance spectroscopy.  
 
Singlet oxygen species 
Singlet oxygen sensor green reagent is highly selective for singlet oxygen and while  
simultaneously showing no appreciable response to other ROS. Prior to its reaction with 
singlet oxygen, it exhibits weak fluorescence with excitation peaks at 372 and 393 nm and 
emission peaks at 395 and 416 nm. In the presence of singlet oxygen, it emits a green 
fluorescence similar to that of fluorescein. It has a peak excitation spectra of 504nm and a 
peak emission spectra of 525 nm.  
Trans -1- (2’-methoxyvinyl) pyrene can be used for the detection of picomolar quantities of 
singlet oxygen in chemical and biological systems. While this is highly selective for singlet 
oxygen species, this probe also has the advantage of not reacting with activated oxygen 
species such as hydroxyl radical, superoxide or hydrogen peroxide.   
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Nitric oxide 
The nitric oxide radical is very unstable and is readily oxidized to the nitrosium cation 
(NO+) which is moderately stable in aqueous solutions but highly reactive with 
nucleophiles or other nitrogen oxides.  
The most successful indicator for nitric oxide is 4, 5-diaminofluorescein diacetate (DAF-2 
acetate) developed by Kojima (Kojima et al 1998). As with other fluorescein diacetates, 
DAF-2 diacetate is membrane permeant and is deacetylated by intracellular esterases to 4, 
5-diaminofluorescein (DAF-2). DAF-2 remains nonfluorescent until it reacts with the 
nitrosonium cation produced by spontaneous oxidation of nitric oxide to form a fluorescent 
heterocycle which becomes trapped in the cells cytoplasm. DAF-2 has been used to identify 
individual nitric oxide-producing neurons in brain slices in both living plant cells and in 
mitochondria (Brown et al 1999, Foissner  et al 2000, López-Figueroa et al 2000).  
DAF-FM (4-amino-5-methylamino-2',7'-difluorofluorescein) and its diacetate derivative 
(DAF-FM diacetate) have significant utility for measuring nitic oxide production in living 
cells or solutions.  
 
Figure DAF-FM 
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There are several other reagents available including anti-nitrotyrosine antibody capable 
of  detecting nitrotyrosine. Nitrotyrosine is associated with a large number of diseases 
including Multiple sclerosis, Alzheimers disease, Parkinsons as well as being indicative of 
vascular and tissue injury from ischemia-reperfusion injury. There are several pathways 
suggested for the formation of tyrosine nitrotyrosine. Nitric oxide (NO) can interact rapidly 
with superoxide (·O2-) to form peroxynitrite  (OONO-) which is a potent oxidant of 
aromatic, aliphatic and sulfhydryl residues (MacMillan-Crow et al 1996). Heme 
peroxidases, such as myeloperoxidase and eosinophilperoxidase have been shown to utilize 
hydrogen peroxide (H202) to oxidize nitrite (NO2-) and catalyze tyrosine nitration (Kilinc et 
al 2001). Additionally other heme proteins such as hemoglobin and catalase may contribute 
to tyrosine nitration using NO as a substrate (Grzelak et al 2001). Tryptophan resides can 
also be oxidized by peroxynitrite (Kato et al 1997).  
Peroxynitrate 
There are a number of assays available for the detection of peroxynitrite including the 
probe hydroxyphenyl fluorescein developed by Nagano et al (Nagano et al 2003). Although 
this particular assay is not specific for peroxynitrite, it also detects hydroxyl and 
peroxynitrite radicals (ONOO-), Under oxygen, ●NO is converted to No-derived nitrogen 
oxides (ONOO● and H203).  
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1.6 Optical and technical aspects of the Heidelberg 
Confocal Scanning Laser Ophthalmoscope.  
For our project, we sought to acquire live images of RGCs in adult Long-Evans rats. 
Because of the challenges of imaging such a small area with high resolution, we chose a 
confocal scanning laser ophthalmoscope, Heidelberg engineering. We will refer to this as 
cSLO in the following text which explains the rationale behind our choice of this apparatus. 
We chose this particular model as it had dual lasers.  
According to recent studies, confocal scanning systems have at least 15 dB better signal-to-
background ratio than any fundus camera based digital imaging system for imaging the 
retina (Bellman et al 2005, O Connor et al 1999). Indeed some studies even demonstrated 
the risk of misdiagnosis when a fundus camera image is used instead of a cSLO (Flower et 
al 1999).  
The confocal scanning laser ophthalmoscope from Heidelberg engineering has three laser 
sources, namely the indocyanine green excitation diode laser (excitation wavelength of 785 
nm, absorption spectra from 800-900 nm), infrared reflectance diode laser (excitation of 
820 nm) and finally the solid state saphire laser (excitation at 488 nm and absorption 
spectra of 500 – 650 nm). This apparatus is already used in clinical ophthalmology for 
examining the retinal vasculature and structural features and abnormalities of the retina in 
humans. In our project the fact that there were a number of different lasers, each with 
unique excitative and emissive wavelengths means we could use different labeling dyes and 
examine their fluorescence simultaneously by simply changing the laser used to view the 
retina at that particular timepoint.  
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Resolution provided by the HRA2 is 5 µm/pixel resolution, while a fundus cameras 
produces 15 to 18 µm/pixel. The HRA2 produces 1536 X 1536 pixels with 30-degree field 
of view in high resolution mode or 768 X 768 in standard mode. There are three fields of 
view available on the HRA2 , namely 30 X 30 degrees, 20 X 20 degrees and 15 X 15 
degrees.    
The term ‘confocal’ means that the imaging system uses both a point source as well as a 
point detector, which have a common focal point. As a result of this, the scattered light 
does not fall on the detector. This improves signal/background ratio significantly. In 
addition to this, the use of a point source and a point detector somewhat simplifies the lens 
requirements as light travels along a principal ray. The ideal optical system should be 
diffraction limited, a goal that can be closer to realisation with in a confocal imager than a 
fundus camera system (Barttsch DU et a 1994, Barttsch DU et al 1995).  
As we use a point source in the confocal imaging system, the retina must be therefore 
scanned horizontally and vertically in order to create a two-dimensional image. This is 
called a flying-spot scanner. Lasers are used as light souces as they produce a highly 
collimated beam that is easily scanned and produces a small spot on the retina.  
The fact that the confocal retinal imaging system uses laser light sources also contributes to 
image quality because the highly collimated beam travels through the central, highest 
quality region of the optical system. The narrow plane of focus increases image quality and 
allows the photographer to select the optimal plane to view the pathology.  
 
Confocal retinal imaging systems utilize laser light sources and this contributes to image 
quality because the highly collimated beam travels through the central, highest quality 
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region of the optical system. The narrow plane of focus increases the image quality. The 
broadband white Xenon flash tube used in fundus camera based systems, the narrow-band 
nature of laser illumination as more efficient in exciting the fluorescein and indocyanine 
green.   
In addition to the above features, the HRA also has the ability to acquire images in the z –
plane creating a 3-dimensional view of retinal ganglion cells to a depth of 8 mm using 
serial slices in the z-plane.  Potentially this could enable us to detect fluorescence present at 
a deeper level of the retina, not present on the surface. Confocal scanning laser microscopy 
has a range of existing and potential clinical applications varying from quantitative 
asssessment of optic disc size in conditions such as papilledema (optic disc swelling) and 
serial assessments of optic disc in glaucoma (Mulholland et al 1998, Chen et al 2007, 
Greenfield et al 2008, Lin et al 2007, Weinreb et al 2004).   
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1.7 Applications of the heidelberg confocal scanning 
laser ophthalmoscope to live in vivo imaging  
From its initial conception over the last 25 years, the ability to image cells in a time-
lapse or even in a real-time fashion using fluorescent probes has permitted a greater 
understanding of the dynamics of cellular processes (Lichtman et al 2003, Lichtman et al  
2001,  Kortuem et al 2000, Wigston et al 1990, Herrera et al 1990, Lichtmamn et al 1987). 
Recent studies have demonstrated that the confocal scanning ophthalmoscope (cSLO) can 
be utilised for real-time in vivo imaging of RGCs in adult rats. Using the prototype Zeiss 
confocal laser scanning ophthalmoscope (cLSO), the pioneering studies by Cordeiro et al 
demonstrated apoptosis could indeed be imaged live in rats and used immunohistochemical 
identifcation of apoptotic cells in the retinas subsequently to confirm this (Cordeiro et al 
2004). In her methodology she labeled RGCs undergoing apoptosis using intravitreal 
injections of  Alexa Fluor 488-labeled annexin 5. This is a protein which has a strong 
affinity for phosphatidylserine when in the presence of Ca2+. Phosphatidyl serine is an 
anionic phospholipid that is enriched in the inner leaflet of plasma membranes. In the early 
stages of apoptosis, Annexin 5 is externalised from the inner to the outer cell membrane, 
before DNA fragmentation and nuclear condensation occur.  Previous studies have 
confirmed its ability to act as a marker for apoptosis both in vivo and in vitro (Hendrikus H 
et al, Laxman et al 2002, Zhou et al 2008). As the excitation and emission wavelengths of 
Alexa Fluor (excitation maximum 495 nm, emission maximum 519 nm) coincide with the 
respective excitation and emision wavelengths of the  laser on the HRA2  (excites at 488 
nm , emission peak 500– 650 nm), it is possible to directly image the apoptotic cells which 
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fluoresce when excited by the diode laser. However the process of cell labeling is not 
without its difficulties. Potential drawbacks of this labeling technique include its 
invasivesness and also the risk of damaging the RGC body or axons during the labeling 
process.  
Higashide et al also demonstrated the successful retrograde labeling technique using DiA 
and imaging using the solid state saphire laser (excitation at 488 nm and absorption spectra 
of 500 – 650 nm) to excite the unique spectra of DiA (Max excite 450 nm, Max Emit 600 
nm) (Higashide et al 2006).  Furthermore more recent studies demonstrated the ability of 
the cSLO to image dendrite and axonal detail in RGCs of the macque monkey (Gray et al 
2008).  
Other studies have opened the window further on the massive potential of live in vivo 
imaging using the HRA2. This repertoire includes the  observation of apoptosis in vivo 
following insults such as laser burns induced by the Neodymium-Yttium Aluminium 
Garnet (YAG) laser  (Schmitz-Valckenberg 2008) and correlation of laser induced burns  In 
another more recent paper Eter et al used CX3CR1GFP/+ knockin mice, in which 
macrophages, dendritic cells and microglia cells are constitutively fluorescent and then 
examined the distribution of these cells following argon laser treatment to the retina (Eter et 
al 2008). With further technical development, this technique has a myriad of potential 
applications in the human model including the monitoring of inflammatory responses to 
various treatments, adjusting treatments and titrating based on response. Apoptosis has also 
been observed in vivo following intravitreal injections of the apoptosis-inducing agent 
staurosporine (Maass et al 2008). More recent novel applications of the potential imaging 
capacity of the HRA2 have focused on a less invasive technique involving modification of 
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the cSLO. This was done by incorporating a laser to image cyan fluorescent protein 
(excitation 460 nm, 490 nm detection filter) in transgenic mice (Feng et al 2000) in which 
the Thy-1 promoter sequences drive the expression of the enhanced cyan fluorescent 
protein, designated Thy1-CFP (Feng et al 2000). Superior colliculus labeling and 
subsequent imaging of RGCs using the HRA2 was also performed with DiI (Max excitation 
553 nm, Max emission 570 nm) (Leung CK et al 2008). Retinal flat mounts were once 
again used as a confirmatory test. Other recent studies have used similar transgenic mice 
but with upregulated yellow fluorescent protein and imaged in a similar fashion using the 
confocal laser scanning ophthalmoscope and the argon laser incorporated into the system 
(Max excitation 514 nm, 530-600 nm band pass filter) (Walsh et al 2008).  
Examination of the retinal nerve fiber layer can also be a good measure of the severity and 
distribution of RGC death and in another recent paper from Japan (Kawaguchi et al 2006) it 
was shown to be possible to quantitatively measure RNFL thickness and note the 
progressive decrease over a four week period following optic nerve crush.  
 
1.8 Presence of oxidative stress in retinal disease 
Retinal ganglion cells undergo apoptosis after axonal injury. There are many retinal 
diseases such as retinal artery occlusion and retinal vein occlusion which involve a 
compromise in the circulation to the retina with resultant production of oxidative species 
and death of retinal ganglion cells. The optic neuropathies include glaucoma, traumatic 
optic neuropathy have also been proposed to involve a similar mechanism.  
Several other retinal diseases are proposed to involve the induction of oxidative stress using 
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the amino acid glutamate. These include glaucoma, diabetic retinopathy and various 
forms of retinal ischemia (Osborne et al 1999). Glutamate has been implicated in retinal 
ganglion cell death after acute insult and although it is present in synaptic nerve terminals 
in millmolar concentrations, the extracellular concentrations are normally high only during 
short periods of synaptic transmission. However certain forms of injury result in extended 
periods of elevated extracellular glutamate levels. High levels of extracellular glutamate 
have been shown to be toxic to nerve cells via two distinct processes. The first of these is 
known as excitotoxicity, which occurs through the activation of ionotropic glutamate 
receptors (Rothman et al 1985, Rothman et al 1986). The second process involves a 
programmed cell death pathway called oxidative glutamate toxicity or oxytosis and is 
mediated by a series of disturbances to the intracellular redox system (Tan et al 2001, 
Murphy et al 1989).  
After axotomy there are several proposed mechanisms for death in the apoptotic cascade. 
Reactive oxygen species play important roles in gene expression and intracellular signaling 
and are made primarily during the production of mitochondrial energy. However high 
levels of ROS play important roles in the signaling of cell death in several neuronal systems 
including RGCs. Conversely studies which have demonstrated that with ROS scavengers, 
small reductions in cellular redox state and hypoxic conditions all contribute to the survival 
of RGCS after axotomy. Studies have demonstrated that axotomy of retinal ganglion cells 
leads to an increased production of superoxide anion in the hours following the injury 
(Levin et al 2006). Interestingly in sympathetic neurons, scavenging of superoxide anion 
has been shown to slow apoptosis after nerve growth factor deprivation.  
Other oxidants in retinal disease  such as the sulfhydryl radical have been shown to have an 
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important effect on RGC survival. The sulfhydryl reductant TCEP (tris(2-carboxyethyl) 
phosphine (TCEP) can protect RGCs in the optic nerve crush model and therefore increase 
RGC survival (Swanson et al 2005).        
The peroxide radical, another molecule involved in retinal ganglion cell death. Inhibition of 
lipid peroxidation with tirilazad mesylate blocks RGC death in a culture model simulating 
axotomy (Levin et al 1996).  
Retinitis pigmentosa (RP) refers to a heterogeneous group of inherited human diseases  
that cause primary degeneration of rod and cone photoreceptors. The Royal College of 
Surgeons (RCS) rat is a commonly used animal model of photoreceptor degeneration of 
relevance to RP (Deshpande et al., 1992; LaVail, 1981). There are several lines of evidence 
implying a role for oxygen  in the RCS rat model of retinal  degeneration. Manipulation 
of environmental oxygen  conditions at key stages in the dystrophic RCS rat has 
reportedly been able to modulate the rate of photoreceptor cell death (Maslim et al., 1997; 
Valter et al., 1998; Stone et al., 1999).  
   
Oxidative stress plays an important role in diabetic complications (Baynes et al 1991, 
Kiwluru et al 1991, Kowluru et al 2001, Kowluru et al 2003, Feldmen et al 2003, Brownlee 
et al 2005, Caldwell et al 2005) and reactive oxygen species (ROS) are considered a causal 
link between elevated glucose and metabolic abnormalities important in the development of 
diabetic complications. Retina and capillary cells experience increased oxidative damage in 
the diabetic milieu, and the antioxidant defense mechanism is impaired (Kiwluru et al 1991, 
Kowluru et al 2001, Kowluru et al 2003, Caldwell et al 2005, Kanwar et al 2007). 
Administration of antioxidants to diabetic rats protects the retina from oxidative damage 
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and also from the development of retinopathy. Furthermore, retinal mitochondria become 
dysfunctional and start to leak cytochrome c into the cytosol, and superoxide levels are 
elevated (Kowluru et al 2003).  
Overexpression of the enzyme responsible for scavenging mitochondrial superoxide 
(MnSOD) prevents these diabetes-induced mitochondrial alterations and histopathology 
characteristic of diabetic retinopathy (Kanwar et al 2007, Kowluru et al 2007), thus 
suggesting a major role for mitochondrial superoxide in the development of diabetic 
retinopathy.  
 
MMP-2 (Matriz Metalloproteinase 2) has been proposed to result in the apoptosis of retinal 
capillary cells (Renu et al 2009). The mechanism by which this occurs is not clear but could 
include damage to the mitochondria resulting in leakage of cytochrome c and activation of 
apoptosis. Studies  have shown that the activation of MMP-2 cleaves the nuclear poly(ADP 
ribose) polymerase (PARP), which induces apoptosis via a mitochondrial pathway 
releasing apoptosis-inducing factor from the mitochondria (Kwan et al 2004).  In the 
development of diabetic retinopathy, mitochondrial dysfunction and PARP activation are 
considered important in the accelerated apoptosis of retinal capillary cells (Kowluru et al 
2003, Kanwar et al 2007, Kowluru et al 2006, Kwan et al 2004), thus further supporting the 
role of MMP-2 in the apoptosis of capillary cells. 
 
Oxidative stress is believed to contribute to the pathogenesis of many diseases, including 
age-related macular degeneration (AMD). Although the vision loss of AMD results from 
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photoreceptor damage in the central retina, the initial pathogenesis involves degeneration 
of RPE cells. Evidence from a variety of studies suggests that RPE cells are susceptible to 
oxidative damage. Mitochondrial DNA (mtDNA) is particularly prone to oxidative damage 
compared to nuclear DNA (nDNA). Using the quantitative PCR assay, a powerful tool to 
measure oxidative DNA damage and repair, we have shown that human RPE cells treated 
with H(2)O(2) or rod outer segments resulted in preferential damage to mtDNA, but not 
nDNA; and damaged mtDNA is not efficiently repaired, leading to compromised 
mitochondrial redox function as indicated by the MTT assay. Thus, the susceptibility of 
mtDNA to oxidative damage in human RPE cells, together with the age-related decrease of 
cellular anti-oxidant system, provides the rationale for a mitochondria-based model of 
AMD. 
  
1.9 Biochemical assays in the past to demonstrate the 
presence of oxygen species in retinal disease. 
There have been numerous methods in previous papers which have attempted to image 
reactive oxygen species (ROS) however these have primarily involved the in vitro or ex 
vivo models.  
One such assay which was used to image reactive oxygen species was H2DCF-dA. This is a 
non-fluorescent compound which accumulates within cells upon deacetylation. H2DCF then 
reacts with ROS to form fluorescent dichlorofluorescein (DCF). This has been used to 
demonstrate the accumulation of ROS in the Retinal Ganglion Cell- 5 line (RGC-5) in 
studies which have utilized various inducers of oxidative stress including  hydrogen 
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peroxide and tert-butyl peroxide (t-BOOH) (Maher et al 2004). This study also 
demonstrated that ROS are produced endogenously by mitochondria using the same reagent 
to image ROS.    
Other oxidative species which have been examined include lipoxidation products such as 4-
Hydroxy-2-nonenal (HNE) adducts (Liu et al 2003, Sayre et al 1997, Uchida et al 2003) 
and the expression of heme oxygenase-1 (HO-1), a common oxidative stress-induced 
protein (Elbirt et al 1999, Schipper et al 2004, Smith et al 1994). In one study (Liu et al 
2007) the RGC-5 cell line was again used with western blotting used as the technique to 
ascertain the total amount of HNE protein adducts formed, the calcein AM live/Dead 
viability assay was used to calculate cell survival. In this assay, polyanionic calcein is 
retained within live cells producing an intense uniform green fluorescence 
(excitation/emission, 495/515 nm). Ethidium homodimer which normally is excluded, 
enters cells with damaged membranes and undergoes a 40-fold enhancement of 
fluorescence on binding to nucleic acids (excitation/emission 495/635 nm). Cell number 
and viability was also measured in the RGC-5 cells using 3-(4, 5-dimethylthiazol-2yl)-2, 5-
diphenyl tetrazolium bromide (MTT).    
Finally RGC superoxide levels in situ have also used HEt (Lieven et al 2006). As decribed 
later in this work, HEt exhibits weak fluorescence and is oxidized by the superoxide anion 
to ethidium (excitation 480 nm, emission 586 nm). HEt enters the cell and after oxidation 
accumulates in the nucleus where it binds DNA and thereby undergoes a small shift in its 
emission spectrum to 567 nm. In this study RGC cells from Long-Evans rats were used (ex 
vivo model) and the RGCs were then identified in mixed retinal cultures using DAPI 
(excitation 330 nm, dichroic 400 nm, emission 450 nm).  
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Previous models have incorporated a model in which excitatory amino acids are injected 
intravitreally  (NMDA, kinate, AMPA) to induce RGC damage. (Vorwek et al 1996). 
Intravitreal injection of NMDA led to the appearance of internucleosomal fragmentation of 
retinal DNA and of terminal transferase dUTP nick end labeling (TUNEL) positive nuclei 
in the inner retina. Ultrastructural features consistent with classis apoptotic changes were 
noted in degenerating cels in the RGC layer and the inner nuclear layer. Control retinas 
given vehicle or NMDA plus the glutamate receptor antagonist MK-80 1 did not show 
these changes. In this model simultaneous administration of NMDA and a caspase inhibitor 
also abolished or attenuated the loss of RGC in the retina. Therefore NMDA- induced 
excitotoxicity involoved apoptosis and caspases in their phometric analysis of retinal 
damage in NMDA- injected eyes also showed that BDNF, nipradiol, MK-801 or eliprodil 
could protect inner retinal cells. In other studies measurements of intravitreal glutamate 
levels indicated an increase in this excitatory amino acid in the vitreous after NMDA 
injection (Kapin et al 1999, Kido et al 2000, Mizuno et al 2001, Morizane et al 1997).  
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Chapter 2 Aims and hypothesis  
Hypothesis 
Reactive oxygen species not only are generated as a result of cellular injury, but also serve 
as signaling molecules for a variety of critical processes, including mitosis and cell death. 
We previously reported that injury to RGC axons induces a burst of superoxide within the 
cell body, probably of mitochondrial origin (Lieven et al, 2006). We now propose to 
describe a method for imaging of reactive oxygen species within the retina of the living 
animal using a confocal scanning laser ophthalmoscope called the Heidelberg Retina 
Angiograph 2 (HRA2) equipped with dual lasers. 
  
Aims 
We sought to examine whether we could detect ROS in RGCs in the live animals, by using 
chemical inducers. Our second aim was to determine whether crushing of the optic nerve 
could induce ROS.    
 
As already outlined in the previous chapter, the majority of studies which examined 
oxidative stress in retinal ganglion cells have used either the in-vitro model (eg RGC-5 cell 
line) or the ex vivo model (Liu et al 2007, Swanson et al 2005). In our study we attempted 
to examine oxidative stress and retinal ganglion cells but take this one step further into the 
in vivo model and actually image oxidative species in real time in the live model. Although 
the monkey model is the closest experimental one to the human, it remains difficult in 
terms of economics, animal numbers and the animal housing space required for such a 
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study. For this reason the rat model was choosen.   
The decision regarding the type of anesthezia to use took experimental times, preservation 
of corneal clarity as well as animal comfort into consideration. Initially consideration was 
given to intraperitoneal xylocaine and ketamine, however given the invasiveness as well as 
the duration of the surgery, deep anesthesia using inhaled isofluorane was used. This 
allowed better control of level of anesthesia and duration of the  experiment.  
 
In order to confirm the filters on the HRA2 were functional we performed a fluorescein 
angiogram in which fluorescein dye was injected intravenously into the rat and images 
were taken of the retina at time intervals. Fluorescein was used as the excitation/emission 
spectrum was the same as one of the lasers on the HRA2.  
 
In order to correctly label the retinal ganglion cells, gelfoam soaked in the fluorescent dye 
(ICG) was placed adjacent to the superior colliculus (SC) so that the dye would permeate 
the SC and therefore travel retrogradely with the retrograde transport system in retinal 
ganglion cell nerve axons along the pathway already described in the introductary chapter 
and finally end in the retinal ganglion cell body in the retina. Again various retinal ganglion 
cell markers were given consideration, however because the excitation/emission specta 
parameters were of prime consideration, there were only a small number of markers which 
qualified for inclusion. In addition to this, consideration was given to the fact that another 
dye used to mark oxidative species would be used and therefore the excitation/emission 
spectra for this agent needed to be different and coincide with the second laser on the 
HRA2. 
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Corneal clarity and image optimisation were also considered in the planning stages for 
the study and various methods including balanced salt solution, 0.9% sodium chloride as 
well as saran wrap covering on the cornea were given consideration.  In addition we also 
injected the diluents (0.9% sodium chloride) intravitreally alone and in combination in 
order to determine if they affected the clarity/fluorescence.  
 
In order to induce oxidative stress various methods were used. This was done in order to 
verify if some of the compounds known to induce oxidative stress in the in-vitro and ex 
vivo models were also able to induce it in the in vivo model. Intravenous injections were 
considered as a delivery technique, however it was difficult to calculate the dose delivered 
to the retinal ganglion cells when administered systemically. In addition the systemic side 
effects of many of these compounds had not been investigated and using systemic methods 
of delivery risked introducing bias into the study. Intravitreal injection was an effective 
method of delivery in terms of its efficacy and ones ability to accurately calculate its 
concentration. It can be injected into the space directly adjacent to retinal ganglion cells and 
permeated them directly which added to its attractiveness as a method of delivery.  
Menadione (Nguyen et al 2003) has been used in ex vivo studies  to generate intracellular 
superoxide anion by redox cycling by the addition of 1 mM to the cultures. Therefore it was 
appropriate to use a similar intravitreal concentration in this study and doses were 
calculated based on this.  
 
HEt was used as this had already been used as a marker of oxidative radicals, it fluoresces 
at a different spectrum when oxidized and additionally the excitation/emission spectrum 
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matched those on the HRA2.  
 
In order to induce oxidative stress on the optic nerve, optic nerve crush was performed 
using the already standard protocol (Morrison et al 1997, Yoles et al 1997). Currently there 
are no other models available in the literature  
 
List of experiments which will be used to achieve our aims  
Imaging of the retinal nerve fiber layer 
4.1 Imaging of the retinal nerve fiber layer using the infra-red and red-free filters.  
4.2 Imaging the retinal nerve fiber layer and determining the best method of preserving 
corneal clarity 
4.3 Imaging the retinal nerve fiber layer following optic nerve transection  
4.4 Examining the effect of intravitreal injection of 0.9% sodium chloride  
 
HRA2 detection of fluorescent species 
4.5 Quantifying the fluorescence of ICG, dihydroethidium and its derivatives using the 
HRA2 
4.6A Detecting retinal ganglion cells using ICG  
4.7 Examination of fluorescence pattern following injection of ICG into the optic nerve 
4.8 Examination of fluorescence following injecting the optic nerve with DiO 
4.9 Examination of fluorescence following intravenous injection of fluorescein  
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Markers of oxidative species : HEt  
4.10 A Examination for background fluorescence of HEt in the absence of oxidative factors 
in the in vivo model and determining the optimum concentration 
4.10 B  Demonstrating that HEt does not react with hydrogen peroxide  
4.10 C Examination of the fluorescence patten following intravenous injection of ethidium 
bromide 
4.11 Examination of fluorescence pattern following intravitreal injection of menadione and 
intravenous injection 
4.12A Examination of fluorescence patterns of a mixture of Menadione and HEt when both 
are injected intravitreally 
4.12B Examination of fluorescence pattern following intravitreal injection of menadione 
and intravenous injection of HEt  
4.13 Examination of fluorescence pattern following the injection of ferrous sulfate and 
dihydroethidium intravitreally 
 
Markers of oxidative species : DCFDA  
4.14A Determination of optimal intravitreal concentration of DCFDA  
4.14B Fluorescence pattern following injection of DCFDA (intravenously) and hydrogen 
peroxide (intravitreally).   
4.14C Demonstrate that DCFDA and hydrogen peroxide do not react when injected 
intravitreally 
4.14D Examination of fluorescence following DCFDA intravenously and Menadione 
intravitreally.  
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Retinal ganglion cells after crush  
4.15 Examining the effect of optic nerve crush on retinal ganglion cells labelled with ICG 
4.16 Imaging superoxide following optic nerve crush using CMH2DCFDA  
4.17 Labeling retinal ganglion cells with ICG and using DCFDA to examine for reactive 
oxygen species following optic nerve crush. 
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Chapter 3 Materials and Methods 
In the next few paragraphs the principles and rationale behind the procedures are explained 
and following this the steps in performing the specific experiments are detailed. The 
annotation of the experimental methods in this chapter correspond to the same ones in the 
next chapter with the results (eg experiment 3.10A corresponds to 4.10A).  
 
Anesthesia  
Optimizing animal comfort and minimizing pain during experiments was an important part 
of this study.  
Anesthesia is administered at prescribed concentrations (see table 4.1 for dose). Check 
animal is asleep (response to pain, tail manipulation etc). Rodents are observed for signs of 
distress in the perioperative period (poor grooming, decreased appetite etc as outlined in 
standard animal handling protocols) and additional doses of analgesia and anesthetic will be 
administered as required. The choice between inhalational anesthesia (isofluorane) versus 
intraperitoneal injections (ketamine and xylocaine) was based on optimizing animal 
comfort whilst staying within the time constraints of the surgery. Some procedures took 
longer (eg superior colliculus labeling), particularly initially as there was a learning curve 
and therefore required the use of inhalational anesthesia. Both methods of anesthesia 
resulted in loss of corneal blink reflex during the procedure and therefore labrilube was 
place on the animals cornea at the start of each procedure in order to minimize this.  
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 Figure 3.1 A 
 
Fluorescein angiography 
As already outlined in the previous chapter, fluorescein angiography is performed to verify 
that one of the HRA2 laser functions (excitation 488 nm/ emission 500-650 nm).  
Fluorescein is made up at a concentration of 25g in 10 ml diluting medium. Place the 
anethetized Long-Evans rat (using standard protocol mentioned above already and 
mantaining corneal hydration as above) on the viewing platform of the HRA2. 
The tail is warmed for about 10-15 minutes before starting using the infra-red heat lamp on 
with the animals in the cage for about 10-15 minutes. This causes vasodilatation and 
therefore facilitates visualization of the  tail veins. Once the tail is warmed place the rat on 
the HRA2 platform ready to be imaged. A piece of cotton gauze is used to remove the 
scales from the tail by holding the tip of the tail and scraping the tail with the gauze in a 
direction towards the rats head. Again this process makes visualization of the tail veins  
easier. The tip of the tail is examined for a vein ideally (in adult rats) at about 3 cm from 
the end in the lateral position is optimal. The closer you go to the thicker part of the tail, the 
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more muscle so it gets more difficult, despite the fact that the veins are larger.  
Work towards the head of the rat, making as few venepunctures a possible to avoid 
collapsing the venous system as all the veins are interconected. A butterfly needle of 30G is 
used with a 1 ml syringe attached to the butterfly, ideally with the syringe barrel fixed in a 
clamp so that there is no movement when you insert the needle. The area to be injected is 
cleaned with an alcohol swab to reduce infection. The needle is inserted in a parallel 
direction to the tail vein with the tip of the needle pointing towards the head of the rat. 
When a flashback is seen in the needle, try to avoid drawing the plunger as the vein may 
collapse. Once the flash is seen, inject material slowly.   
Wait about 1 second after injecting before removing the needle to avoid the injected 
solution leaking out. After the needle is removed, a small amount of pressure is put on the 
tail with a gauze to prevent leakage. Imaging is done using the fluorescein filter at serial 
intervals of approximately 30 seconds. 
 
 
Retrograde labeling of retinal ganglion cells with fluorescent 
markers  
Inhalational anesthesia is set at oxygen flow rate of 2.5 L/minute, isofluorane of 5% for 
approximately 5 minutes until the animal is anesthetized in an anesthesia closed chamber. 
The animal is fixed in the holding device. The animal is checked for depth of anesthesia 
Check animal is asleep (response to pain, tail manipulation etc). Lacrilube is placed in both 
corneas in order to maintain corneal hydration. The head area is shaved with an electric 
razor. Chlorhexidine is used to clean the area surrounding the planned incision.  
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 Figure 3.1 A 
 
A longitudinal incision is made in the centre of the head going from an imaginary line 
connecting both eyes to behind the midpoint of the ears. Skin retractors are placed and 
secured using tape. The fascia is cut and removed until the bony surface is exposed and 
suture lines are clearly delineated. See diagrams below for anatomical details. 
Cotton wool is soaked in sterile saline to control bleeding. The bony surface is  immersed 
in saline for a few minutes if necessary to control hemorrhage. 
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Lambda 
Midline suture 
Bregma 
Drilled hole 
Area of interest highlighted in the next 
diagram 
1mm 
1mm
mm 
1mm
Figure 3.1 C Diagram showing markings and areas of interest on rat skull.  
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Figure 3.1 D Diagram showing markings and areas of interest on rat for superior 
colliculus labeling with superior colliculus highlighted with red arrow. 
 
The area where the holes will be drilled is marked with marker pen. Two holes are drilled 
in the skull using anatomical markers to locate exact site. The hole is 1 mm from lambda 
suture and 1 mm from midline suture and approximately 3mm in diameter, although this 
will vary slightly depending on the age of the rat. Bleeding is controlled using normal 
saline. Dissect to the level of superior colliculus using gentle suction with a 20G needle 
White matter is encountered, then grey matter and then CSF. Caution is exercised at this 
point to avoid aspirating the superior colliculus. It appears as a yellow vascular structure 
amongst the adjacent grey matter. Cotton wool is soaked in normal saline to control 
hemorrhage. The superior colliculus is punctured gently with tip of a 25G needle. 
Hemorrhage is controlled using cotton soaked in saline. Gelfoam (dimensions 2 mm x 2 
mm x 2 mm) soaked in desired dye is inserted into the area around the superior colliculus. 
Skin is closed using 5-0 vicryl. Polysporin is applied to the skin. Lacrilube is applied to 
both eyes again. Buphenorphine sc (see table 4.1A for dose) is given for analgesia. The rat 
is removed from the anesthetic apparatus and placed in the transportation cage. The rat is 
placed on a clean cotton napkin in the cage with rat food on the napkin beside it.  This 
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minimizes the chances of contaminating its wound and eyes with sawdust and dust as it 
wakes up. The water bottle is filled. Mark the cage with the experiment details.  
 
Intravitreal injections 
Anesthetize the rat using intraperitoneal lidocaine and xylocaine as already outlined above. 
Inject 4 microliters of normal saline into right eye. Make an incision in lateral aspect of the 
conjuctiva of the right eye. Use the surgical limbus as your landmark and insert the 
hamilton 32 gauge syringe needle just posterior to this and inject 4 microliters of normal 
saline into the vitreal compartment of the eye. Following injection examine the fundus 
using the direct ophthalmoscope to ensure there is no damage to the retina of the animal. 
Left eye will be the control. Maintain corneal hydration using 0.9% sodium chloride topical 
drops applied to the cornea. Place the anethetized Long-Evans rat (using standard protocol 
mentioned above already and mantaining corneal hydration as above) on the viewing 
platform of the HRA2 and image at intervals. 
 
Figure 3.1 E Diagram showing Hamilton syringe  
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Intravenous tail injections 
We performed intravenous delivery of some fluorescent agents in order to find the optimal 
method for administering these substances.  
Place the anethetized Long-Evans rat (using standard protocol mentioned above already 
and mantaining corneal hydration as above) on the viewing platform of the HRA2. 
The tail is warmed for about 10-15 minutes before starting using the infra-red heat lamp on 
with the animals in the cage for about 10-15 mins. The tail veins are seen more prominently 
towards the end of the 15 minutes. Once the tail is warmed place the rat on the HRA2 
platform ready to be imaged.  A piece of cotton gauze is used to remove the scales from the 
tail by holding the tip of the tail and scraping the tail with the gauze in a direction towards 
the rats head. This makes visualization of the tail veins  easier. 
The tip of the tail is examined for a vein ideally (in adult rats) at about 3 cm from the end in 
the lateral position is optimal. The closer you go to the thicker part of the tail, the more 
muscle so it gets more difficult, despite the fact that the veins are larger. Work towards the 
head of the rat, making as few venepunctures a possible to avoid collapsing the venous 
system. A butterfly needle of 30G is used with a 1 ml syringe attached to the butterfly, 
ideally with the syringe barrel fixed in a clamp so that there is no movement when you 
insert the needle. The area to be injected is cleaned with an alcohol swab to reduce 
infection. The needle is inserted in a parallel direction to the tail vein with the tip of the 
needle pointing towards the head of the rat. When a flashback is seen in the needle, try to 
avoid drawing the plunger as the vein may collapse. Once the flash is seen, inject material 
slowly. Wait about 1 second after you inject before removing the needle to avoid the 
injected solution leaking out. After the needle is removed, a small amount of pressure is put 
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on the tail with a gauze to prevent leakage. Imaging is done using the fluorescein filter at 
serial intervals of approximately 30 seconds.  
 
Imaging the retina  
Anesthetize the rat (see figure 3.1 A). Check animal is asleep (response to pain, tail 
manipulation etc). Rodents will be observed for signs of distress in the perioperative period 
(poor grooming, decreased appetite etc as outlined in standard animal handling protocols) 
and additional doses of analgesia and anesthetic will be administered as required. Animal is 
placed on the viewing platform on the HRA2. Cornea is frequently lubricated with balanced 
salt solution to maintain corneal clarity.  
 
Optic Nerve Crush  
As already outlined in the preceding chapters, optic nerve crush has been previously 
demonstrated to induce the production of oxidative species in the in vivo model.  
Anesthetize the rat (see figure 3.1 A). Check animal is asleep (response to pain, tail 
manipulation etc). Rodents will be observed for signs of distress in the perioperative period 
(poor grooming, decreased appetite etc as outlined in standard animal handling protocols) 
and additional doses of analgesia and anesthetic will be administered as required. 
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 Figure 3.1 A 
 
Put lacrilube ointment in both of the rats eyes to maintain corneal hydration. Shave the 
lateral side of the right temporal area with electric razor to minimize contamination from 
animal hairs. Use chlorhexidine to clean the area surrounding the planned incision. The 
lateral canthus is clamped with a fine hemostat for 5 seconds and then incised. A lateral 
conjunctival incision is made using a microscissors (Fine Surgical Tools, Vancouver 
Canada) and using blunt dissection the lateral aspect of the orbit is exposed until finally the 
retrobulbar portion of the optic nerve is visualized.  
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 Figure 3.1 F 
  
 Figure 3.1G  
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 Figure 3.1H 
 
 Figure 3.1 I 
 
Using the fine noserrated forceps (Fine surgical Tools, Vancouver, Canada), the optic nerve 
is crushed for 5 seconds at approximately 3 mm posterior to the globe.  
The wound is closed with 5-0 vicryl sutures and bacitracin applied to reduce chances of 
infection. Animals are observed until recovered from anesthesia. The contralateral optic 
nerve in each rat serves as a control for each rat and therefore is not operated on.   
 
 88 
Optic nerve transection  
As already outlined in the preceding chapters, optic nerve transection has been previously 
demonstrated to induce the production of oxidative species in the in vivo model.  
Anesthetize the rat (see figure 3.1 A). Check animal is asleep (response to pain, tail 
manipulation etc). Rodents will be observed for signs of distress in the perioperative period 
(poor grooming, decreased appetite etc as outlined in standard animal handling protocols) 
and additional doses of analgesia and anesthetic will be administered as required. 
 
 Figure 3.1 A 
 
Put lacrilube ointment in both of the rats eyes to maintain corneal hydration. Shave the 
lateral side of the right temporal area with electric razor to minimize contamination from 
animal hairs. Use chlorhexidine to clean the area surrounding the planned incision.   
The lateral canthus is clamped with a fine hemostat for 5 seconds and then incised. 9. A 
lateral conjunctival incision is made using a microscissors (Fine Surgical Tools, Vancouver 
Canada) and using blunt dissection the lateral aspect of the orbit is exposed until finally the 
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retrobulbar portion of the optic nerve is visualized.  
 
 Figure 3.1F 
 
  
 Figure 3.1 G  
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 Figure 3.1 H 
  
Using the fine scissors (Fine surgical Tools, Vancouver), the optic nerve is completely 
transected approximately 3 mm posterior to the globe. The wound is closed with 5-0 vicryl 
sutures and bacitracin applied. Animals are observed until recovered from anesthesia. The 
contralateral optic nerve in each rat serves as a control for each rat and therefore is not 
operated on.   
 
Specific experimental details  
Imaging of the retinal nerve fiber layer 
3.1 Imaging of the retinal nerve fiber layer using the infra-red and red-free filters.  
For this experiment we used ten adult Long-Evans rats which has had no previous ocular 
injection/manipulation or other interventions previously performed on them. Adult rats 
were anethetized (see protocol already described) using lidocaine and ketamine in mixed in 
equal standard concentrations injected intraperitonally at a concentration of 100 microliters 
per 100g eg a 100g adult rat had 50 microliters of ketamine and 50 microliters of xylocaine 
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injected intraperitoneally. See table 4.1 A for concentrations of anesthetic stock solution 
used. Image the retina after the application of balanced salt solution to maintain corneal 
hydration.      
Table 3.1 A 
 Duration 
of 
procedure  
 Medication Desired 
effect  
Dose Method 
administration  
15 minutes  Ketamine Anesthezia  40 – 80 mg/kg i.p. 
15 minutes  Xylazine Anesthezia  5 -10 mg/kg i.p. 
15 minutes  Buphrenorphine  Analgesia  0.01-
0.5mg/kg 
s.c. 
15 minutes  Isoflurane (if above 
methods are 
insufficient) 
Anesthezia 3-5 L/minute Inhalation  
 5 minutes Intravitreal 
hydrogen peroxide  
See below 0.2 mM 
 
Intravitreal 
injection  
5 minutes Intravitreal 
dihydroethidium 
(HEt) 
See  below 3.2 mM or 
0.032 mM 
Intravitreal 
injection  
5 minutes Intravenous 
ethidium bromide 
See  below 10 microliters 
of 0.1 % 
ethidium 
bromide 
Intravenous 
injection.  
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3.2 Imaging the retinal nerve fiber layer and determining that the application of 
balanced salt solution and Saran wrap to the cornea was optimal for preservation of 
corneal clarity.  
We wanted to determine the best method for optimization of corneal clarity.  
For this experiment we used three adult Long-Evans rats which has had no previous  
injection/manipulation or other intervention previously performed on them. Adult rats were 
anethetized using lidocaine and ketamine in standard concentrations injected 
intraperitonally at a concentration of 100 microliters per 100g eg a 100g adult rat had 50 
microliters of ketamine and 50 microliters of xylocaine injected intraperitoneally. Place 
BSS alone on one cornea and image through this. Place saran wrap with balanced salt 
solution interposed between this and the cornea and image through this. Compare this with 
the contralateral eye which had balanced salt solution alone. Image each cornea at 15 and 
30 minutes. Corneal clarity was reduced when the image was taken with saran wrap in situ, 
with reduction in detail resolution. However, when the saran wrap was removed from the 
right eye and the retina reimaged without the saran wrap, it was noted that corneal clarity 
was more preserved in this eye compared with the contralateral one which has balanced salt 
solution alone placed at 10 second intervals during imaging to maintain corneal hydration. 
 
3.3 Imaging the retinal nerve fiber layer following optic nerve transection  
As already outlined in previous chapters, optic nerve crush and transection cause the 
production of reactive oxygen species.  
For this experiment we used two adult Long-Evans rats which has had no previous ocular 
injection/manipulation or other interventions previ
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were anesthetized using lidocaine and ketamine in mixed in equal standard 
concentrations injected intraperitonally at a concentration of 100 microliters per 100g eg a 
100g adult rat had 50 microliters of ketamine and 50 microliters of xylocaine injected 
intraperitoneally. See table 4.1 A for the exact concentration of stock solutions of analgesic 
and anesthesia medications used in our experiments. Check animal is asleep (response to 
pain, tail manipulation etc). Rodents will be observed for signs of distress in the 
perioperative period (poor grooming, decreased appetite etc as outlined in standard animal 
handling protocols) and additional doses of analgesia and anesthetic will be administered as 
required. The method used to transect the optic nerve was performed as described in the 
methods section. 
 
3.4 Examining the effect of intravitreal injection of 0.9% sodium chloride  
As sodium chloride would be used as the diluent in many experiments, it was important to 
establish that sodium chloride did not produce any fluorescence.  
For this experiment we used three adult Long-Evans rats which has had no previous ocular 
injection/manipulation or other interventions previously performed on them. 
Anesthetize rat using intraperitoneal lidocaine and xylocaine as already outlined.  
Inject 4 microliters of normal saline intravitreally into the right eye. Make an incision in 
lateral aspect of the conjuctiva of the right eye. Use the surgical limbus as your landmak 
and insert the hamilton 32 gauge syringe needle just posterior to this and inject 4 
microliters of normal saline into the vitreal compartment of the eye. Following injection 
examine the fundus using the direct ophthalmoscope to ensure there is no damage to the 
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retina of the animal. Left eye will be the control. Maintain corneal hydration using 
balanced salt solution topical drops applied to the cornea.   
Place the anethetized Long-Evans rat (using standard protocol mentioned above already 
and mantaining corneal hydration as above) on the viewing platform of the HRA2 and 
image at 15 minute intervals. 
 
HRA2 detection of fluorescent species 
3.5 Quantifying the fluorescence of ICG, dihydroethidium and its derivatives using 
the HRA2 
In order to examine the intensity of fluorescence from various dyes used to image either 
retinal ganglion cells or oxidative species, it was important to explore the intensity of 
fluorescence of their fluorescence at serial concentrations. The computer software 
application known as Image J was used to measure fluorescence on each image. This is a 
program which provides a discrete variable indicating the intensity of the fluorescence in a 
specific area of the image. We measured the fluorescence in the same part of the cuvette 
image in every image to ensure a homogenous sample. Samples were placed at 
approximately the same distance from the HRA2 lens to ensure optimal clarity and 
homogenous samples. Following acquiring each of the values for the intensity at increasing 
concentrations we plotted this on a graph. The sensitivity of the HRA2 can also be varied 
from 100 to 0% and the samples were each imaged at sensitivities from 93% down to 25%. 
These arbitrary numbers were chosen because above 93% the entire image became 
distorted and similarly below 25% the same issue occured.        
Stock concentrations  and then serial dilutions of each of the below solutions up until 1 in 
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1, 000, 000 dilutions.  
• ICG (stock concentration of 25 mg in 1 ml water)  
• Oxy-ethidium (Sigma-aldrich, Canada) 
• Oxy-ethidium-DNA (Sigma-aldrich, Canada) 
The above solutions were placed in polystyrene cuvettes. Polystyrene was used as it 
minimized the absorption of the infrared waves of laser by the material used to hold the 
solution. (100 microliter volume per cuvette) Serial dilutions were then done of each 
solution until 1 in 1, 000, 000 dilutions were reached. In order to standardize the analysis 
for each particular labeling dye, the cuvettes were placed at a fixed distance from the HRA2 
objective lens. This distance was choosen to provide the clearest image possible.  
Images were captured and subsequently analysed using the image J program. 
 
Oxy-Et Standardisation curves  
In order to minimise variations in distance and focal point when comparing different 
concentrations of oxy-Et, the intensity of fluorescence calibration curves were measured 
with all the polystyrene cuvettes containing the oxy-Et-DNA placed at a distance of 3.5 
centrimetres from the HRA2 objective lens and using a 47.50 Diopter setting on the HRA2. 
As previously this distance was choosen to provide the clearest image possible. 
Quantitative values obtained from image J were then plotted.  
 
Oxy-Et-DNA Standardisation Curves 
In order to minimise variations in distance and focal point when comparing different 
concentrations of oxy-Et-DNA, the intensity of fluorescence calibration curves were 
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measured with all the polystyrene cuvettes containing the oxy-Et-DNA placed at a 
distance of 3.5 centrimetres from the HRA2 objective lens and using a 47.50 Diopter 
setting on the HRA2. As previously this distance was choosen to provide the clearest image 
possible. Quantitative values obtained from image J were then plotted on the below chart.  
 
 ICG standardisation curve 
In order to minimise variations in distance and point of focus when comparing different 
concentrations of ICG, the intensity of fluorescein calibration curves were done with all the 
polystyrene cuvettes containing the ICG placed at a distance of 3.3 centrimetres from the 
HRA2 objective lens and using a 46.75 Diopter setting on theHRA2. As previously this 
distance was choosen to provide the clearest image possible. Quantitative values obtained 
from image J were then plotted on the below chart. 
 
3.6A Detecting retinal ganglion cells using ICG  
Retrograde labeling of retinal ganglion cells was performed using techniques already 
described and retinas were imaged prior to labeling and then at 24 hours intervals 
thereafter.  
  
3.7 Examination of fluorescence pattern following injection of ICG into the optic 
nerve 
This experiment allowed us to examine fluorescence patterns following optic nerve 
injection of a fluorescent dye and examine this as a potential route of administration.  
 
 97 
For this experiment we used three adult Long-Evans rats which has had no previous 
ocular injection/manipulation or other interventions previously performed on them. Lateral 
canthotomy and orbitotomy were performed on the right side in a 3 month old Long-Evans 
rat. Injection of 4 uL of ICG (concentration of 25g/10 ml) in retro-orbital area of Optic 
nerve using the 32 gauge Hamilton syringe. Image at 24 hour intervals from the time of 
injection up to and including 7 days post injection. 
 
3.8 Examination of fluorescence following injecting the optic nerve with DiO 
This experiment allowed us to examine fluorescence patterns following optic nerve 
injection of a fluorescent dye and examine this as a potential route of administration.  
 
For this experiment we used three adult Long-Evans rats which has had no previous ocular 
injection/manipulation or other interventions previously performed on them. 
Lateral canthotomy and orbitotomy were performed on the right side in a 3 month old 
Long-Evans adult rat. Exposure of lateral aspect of the optic nerve is described above in 
detail in experiment 3.3.  Injection of 4 uL of DiO (5 mg/100 ul) in retro-orbital optic nerve 
using the 32 gauge Hamilton syringe shown below. Image at 24 hour intervals from the 
time of injection up to and including 7 days post injection.  
 
3.9 Examination of fluorescence following intravenous injection of fluorescein  
In view of the fact that we had considerable difficulty using fluorescent markers with 
excitation in the fluorescein range (488 nm) we performed a fluorescein angiogram on an 
adult live rat to confirm the laser on the HRA2 was functional.  
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Make up solution of fluorescein (excitiation at 488 nm) at a concentration of 25g in 10 ml 
diluting medium. Place the anethetized Long-Evans rat (using standard protocol mentioned 
above already and mantaining corneal hydration as above) on the viewing platform of the 
HRA2. Inject 1 ml of this solution into the tail vein of an adult Long-Evans rat using the 
technique described under the methods section. HRA2 settings recorded were as follows: 
93 % sensitivity, 12.46 diopters, 4.76 micrometers/pixel.  
 
Markers of oxidative species : Dihydroethidium (HEt)  
3.10 A Examination for background fluorescence of HEt in the absence of oxidative 
factors in the in vivo model and determining the optimum concentration 
For this experiment we sought to examine whether there was any fluorescence of one of the 
markers of oxidative species when there was no source of oxidative species.  
 
We used three adult Long-Evans rats which has had no previous  
ocular injection/manipulation or other interventions previously performed on them. 
Anethetize rat as already described above. Inject a total volume of 4 uL intravitreally (2 uL 
of HEt and 2 uL of BSS into each vitreous body). As already explained in previous chapters 
this has been shown to be the optimal volume which can be injected into the vitreous of 
adult rats in previous studies.  
Right eye: final Dihydroethidium concentration 3.2 mM 
Left eye:  final Dihydroethidium concentration 0.032 mM 
Image at 0, 10, 20, 30, 45, 60 minutes, 2, 4, 6, 12, 24 and 48 hours. 
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3.10 B  Demonstrating that HEt does not react with hydrogen peroxide  
In this experiment we wanted to demonstrate that the oxidative species hydrogen peroxide 
did not react with HEt and therefore show that HEt was more specific to reacting with the 
superoxide anion. 
  
For this experiment three adult Long-Evans rats which has had no previous ocular  
injection/manipulation or other interventions previously performed on them. 
Adult rats were anesthetized using lidocaine and ketamine in mixed in equal standard 
concentrations injected intraperitonally at standard concentrations as described previously 
above. Plan of injections and imaging is outlined in table below.  
Table 3.10 B showing time points of injections/manipulations etc  
Time point         Procedure Perfomed  
 Right Eye                            Left Eye           
0 minutes Image  Image  
0 minutes Inject Intravenous 
DCFDA  
Inject Intravenous 
DCFDA  
20 minutes Inject intravitreal 
hydrogen peroxide (0.2 
mM, 4 microliters) 
 
30 minutes Image Image 
45 minutes  Image  Image  
60 minutes  Image  Image  
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3.10 C Examination of the fluorescence patten following intravenous injection of 
ethidium bromide 
For this experiment we sought to examine whether there was any fluorescence with 
ethidium bromide, a substance whose chemical structure bears some resemblance to 
dihydroethidium. In this way we could verify whether there were false positive results. 
 
For this experiment we used three adult Long-Evans rats which had had no previous ocular 
injection/manipulation or other interventions previously performed on them. 
Adult rats were anesthetized using lidocaine and ketamine in mixed in equal standard 
concentrations injected intraperitonally at standard concentrations as described previously 
above. Intravenous injection of ethidium bromide was made and then serial images were 
taken.   
 
3.11 Examination of fluorescence pattern following intravitreal injection of 
menadione and intravenous injection of HEt. 
As already discussed in previous chapters menadione uncouples the redox reaction in 
mitochondria and causes an increase in the production of oxidative species (Nguyen et al 
2003). Therefore by using this compound with HEt we proposed to demonstrate production 
of reactive oxygen species and fluorescence. We choose to administer the HEt 
intravenously to ascertain if this route of administration had any effect on the production of 
fluorescence.  
 
Adult rats were anesthetized using lidocaine and ketamine in mixed in equal standard 
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concentrations injected intraperitonally at standard concentrations as described 
previously above. Intravenous injection of HEt and intravitreal injection of menadione was 
made (using standard concentrations already described in table 3.1A based on 
concentrations used in previous studies) and then serial images were taken.   
  
3.12A Examination of fluorescence patterns of a mixture of Menadione and HEt when 
both are injected intravitreally 
As already outlined in the introduction menadione is a known producer of oxidative 
species. For this reason we wanted to inject it intravitreally and examine whether there was 
any fluorescence when dihydroethidium was injected both intravenously (4.12 B) and 
intravitreally (4.12 A).    
 
For this experiment we used three adult Long-Evans rats which has had no previous ocular 
injection/manipulation or other interventions previously performed on them. 
Rat was anethetized using standard methodology already described above.  
Right eye: HEt (intravitreal injection to achieve a final concentration of 3.2 mM) and 
Menadione (intravitreal injection as already described to achieve intravitreal concentration 
of 10 mM) 
Left eye: HEt 3.2 mM 
Image at preinjection, 0, 10, 20, 30 45, 60 mins, 1, 2, 4, 6, and 12 hours and every 24 hours 
thereafter.   
Overall summary of results demonstrated a speckled pattern of fluorescence but less 
marked in the eye which had both menadione and HEt during first 12 hours,  with an 
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absence of this pattern from 24 – 72 hrs.    
Poor clarity was found in both eyes when imaged at day following injection. The results are 
summarized in the below table. Of note there was some fluorescence present prior to 
injection in both eyes in a diffuse pattern making the results difficult to interpret.  
 
3.12B Examination of fluorescence pattern following intravitreal injection of 
menadione and intravenous injection of HEt  
 
For this experiment we used three adult Long-Evans rats which has had no previous ocular 
injection/manipulation or other interventions previously performed on them. The rat was 
anethetized using standard methodology already described above. Image at preinjection, 0, 
10, 20, 30 45, 60 mins, 1, 2, 4, 6, and 12 hours and every 24 hours thereafter. 
Table 3.12 B showing time points of injections/manipulations etc  
Time point         Procedure Perfomed  
 Right Eye                            Left Eye           
0 minutes Image and then inject 
intravenous HEt  
Image and then inject 
intravenous HEt  
10  minutes Image and then inject 
intravitreal menadione 
 
40 minutes Image Image  
50 minutes Image Image 
90 minutes  Image  Image  
110 minutes  Image  Image  
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3.13 Examination of fluorescence pattern following the injection of ferrous sulfate 
and dihydroethidium intravitreally 
Ferrous sulfate is capable of producing the superoxide anion and in this experiment we 
postulate that its intravitreal injection will produce superoxide anion in vivo (Rogers et al 
2007, Kambayashi et al 2003). 
 
For this experiment we used three adult Long-Evans rats which has had no previous ocular 
injection/manipulation or other interventions previously performed on them. 
Adult rats were anesthetized using lidocaine and ketamine in mixed in equal standard 
concentrations injected intraperitonally at standard concentrations as described previously 
above. As previousy the left eye will act as the control. Intravitreal injection of 0.5 mM 
ferrous sulphate (Sigma Aldrich, Canada) in the right eye. The rats cornea is protected 
using lacrilube ointment. Seventy two hours following this injection, intravitreal injection 
of 0.32 mM dihydroethidium is done in both eyes and 45 minutes following this the retina 
of both eyes is imaged using all four laser frequencies.  
  
Markers of oxidative species : DCFDA  
3.14A Determination of optimal intravitreal concentration of DCFDA  
As already explained in the introductory chapters, DCFDA is a marker of oxidative species 
and therefore we attempted to initially use this to verify the correct concentration using 
those used by previous studies as a guide. 
  
For this experiment we used three adult Long-Evans rats which has had no previous ocular 
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injection/manipulation or other interventions previously performed on them. Adult rats 
were anesthetized using lidocaine and ketamine in mixed in equal standard concentrations 
injected intraperitonally at standard concentrations as described previously above. As 
previously the left eye will act as the control. Intravitreal injections of 3.2 mM , 0.32 mM 
and 0.032 mM DCFDA were performed.   
 
 
 
Table 3.14 part 1 and 2 showing plan of experiment and results 
Time point         Procedure Perfomed  
 Right Eye                            Left Eye           
0 minutes Image and then inject 
3.2 mM DCFDA  
Image 
10  minutes Image  Image  
40 minutes Image Image  
50 minutes Image Image  
90 minutes  Image  Image  
110 minutes  Image  Image  
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3.14B Fluorescence pattern following injection of DCFDA (intravenously) and 
hydrogen peroxide (intravitreally).   
As already explained in the introductory chapters, DCFDA is a marker of oxidative species 
and therefore we attempted to verify if any fluorescence was produced in the presence of 
hydrogen peroxide when DCFDA was administered intravenously. 
 
For this experiment we used three adult Long-Evans rats which has had no previous ocular 
injection/manipulation or other interventions previously performed on them. 
Adult rats were anesthetized using lidocaine and ketamine in mixed in equal standard 
concentrations injected intraperitonally at standard concentrations as described previously 
above.  
Table 3.14 B showing time points of injections/manipulations etc  
Intervention performed in each eye Time point 
OD OS 
Preintervention   
0 minutes Intravenous injection 
DCFDA 
Intravenous injection 
DCFDA 
20 minutes Intravitreal injection 
hydrogen peroxide 
 
30 minutes Image Image 
40 minutes Image Image 
50 minutes Image Image 
60 minutes Image Image 
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1 hour 10 minutes Image Image 
1 hour 20 minutes Image Image 
1 hour 40 minutes Image Image 
 
3.14C Demonstrate that DCFDA and hydrogen peroxide do not react when injected 
intravitreally 
This is a further elaboration on the preceding experiment. As already explained in the 
introductory chapters, DCFDA is a marker of oxidative species and therefore we attempted 
to verify if any fluorescence was produced in the presence of hydrogen peroxide when 
DCFDA was administered intravitreally. Here we are attempting to determine if the route 
of administration has any effect on the production of fluorescence.   
For this experiment we used three adult Long-Evans rats which has had no previous ocular 
injection/manipulation or other interventions previously performed on them. 
Adult rats were anesthetized using lidocaine and ketamine in mixed in equal standard 
concentrations injected intraperitonally at standard concentrations as described previously 
above.  
Table 3.14 C showing time points of injections/manipulations etc 
Intervention performed in each eye Time point 
OD OS 
Preintervention Image Image 
O minutes  Inject intravitreal 
DCFDA 
 
25 minutes Inject intravitreal  
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hydrogen peroxide 
30 minutes Image Image 
40 minutes Image Image 
50 minutes Image Image 
60 minutes Image Image 
70 minutes Image Image 
 
3.14D Examination of fluorescence following DCFDA intravenously and Menadione 
intravitreally.  
As already explained in the introductory chapters, DCFDA is a marker of oxidative species 
and therefore we attempted to verify if any fluorescence was produced in the presence of 
menadione (menadione as explained previously produces oxidative species by uncoupling 
redox reactions in the mitochondria) when DCFDA was administered intravenously. 
  
For this experiment we used three adult Long-Evans rats which has had no previous ocular 
injection/manipulation or other interventions previously performed on them. Adult rats 
were anesthetized using lidocaine and ketamine in mixed in equal standard concentrations 
injected intraperitonally at standard concentrations as described previously above.  
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  Table 3.14D showing time points of injections/manipulations etc  
Intervention performed in each eye Time point 
OD OS 
Preintervention Image  Image 
O minutes  Inject intravenous 
DCFDA 
Inject intravenous 
DCFDA  
15 minutes Image Image 
30 minutes Inject menadione (10 
mM) intravitreally 
 
40 minutes Image Image 
60 minutes Image Image 
80 minutes Image Image 
105 minutes Image Image 
120 minutes Image Image 
 
Retinal ganglion cells after crush  
3.15 Examining the effect of optic nerve crush on retinal ganglion cells labelled with 
ICG 
 
As the optic nerve and therefore retinal ganglion cell axons will be crushed, it was 
important to establish what effect this had on the already established retrograde 
transportation of fluorescent dye to the retinal ganglion cell body fromthe superior 
colliculus. 
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For this experiment we used three adult Long-Evans rats which has had no previous 
ocular injection/manipulation or other interventions previously performed on them. 
Retinal ganglion cells are labeled using the established retrograde labeling technique via the 
superior colliculus already outlined. Image at 24 hour intervals from the time of injection 
up to and including 7 days post injection. 
Table 3.16 showing time points of injections/manipulations etc 
Intervention performed in each eye Time point 
OD OS 
Preintervention Image  Image 
O minutes  Retrograde labeling 
with ICG 
Retrograde labeling 
with ICG  
24 hours Image Image 
24 hours and 10 
minutes  
Optic nerve crush  Optic nerve crush  
48 hours  Image Image 
72 hours  Image Image 
96 hours  Image Image 
120 hours  Image Image 
144 hours  Image Image 
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3.16 Imaging superoxide following optic nerve crush using CMH2DCFDA  
This experiment used CMH2DCFDA (also known as DCFDA) to demonstrate the 
generation of reactive oxygen species following crush.  
 
For this experiment we used three adult Long-Evans rats which has had no previous ocular 
injection/manipulation or other interventions previously performed on them. Adult rats 
were anesthetized using lidocaine and ketamine in mixed in equal standard concentrations 
injected intraperitonally at standard concentrations as described previously. As previously 
the left eye will act as the control. Crush right optic nerve on day 0 and image pre and post 
crush. Inject 3.2 mM intravitreal concentration of CMH2DCFDA intravitreally  at 10 
minutes following crush. Image at 10, 30, 60, 120 minutes and 4 hours, 6 hours, 24 hours 
and 2, 3, 5 and 7 days.  
 
3.17 Labeling retinal ganglion cells with ICG and using DCFDA to examine for 
reactive oxygen species following optic nerve crush  
For this experiment we used three adult Long-Evans rats which has had no previous ocular 
injection/manipulation or other interventions previously performed on them. Adult rats 
were anesthetized using lidocaine and ketamine in mixed in equal standard concentrations 
injected intraperitonally at standard concentrations as described previously above. Image 
using HRA2.  Image the retina. Use technique described above already to retrogradely label 
retinal ganglion cells. using indocyanine green at the superior colliculus. Image at 24 hours 
later. Crush right optic nerve as already described above taking care to preserve retinal 
circulation and verifying this using direct ophthalmoscope.   
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Image immediately afterwards. Inject dihydroethidium intravitreally to achieve a 
concentration of 0.32 mM. Image at 10 minute intervals and at regular time intervals 
thereafter (every 24 hours) following this injection. Table 4.17 illustrates the time points 
and procedures performed.  
 
 
 
Table 3.17 showing time points of injections/manipulations etc  
Intervention performed in each eye Time point from RGC 
labeling OD OS 
Preintervention Image Image 
O minutes  Crush optic nerve  
10 minutes Image  Image  
20 minutes 0.32mM CMH2DCFDA  
intravitreally  
0.32mM CMH2DCFDA 
intravitreally  
30 minutes Image Image 
24 hours Image Image 
48 hours Image Image 
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Chapter 4 Results  
Part one: standardization 
 
HRA2 imaging of retinal nerve fiber layer 
4.1 The retinal nerve fiber layer can be imaged using red-free and infrared filters. 
  
    
Figure 4.1 A     Figure 4.1B 
Infrared image  
Imaging of the right retina in an adult rat under infra-red laser with annotation of the 
structures in the identical image on right. The yellow arrows highlight a part of the image in 
which one can appreciate the the nerve fiber layer striations in greater detail. The red circle 
highlights the optic disc area. The black arrows follow the path of a vessel from the 
peripheral area towards the optic disc.    
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Figure 4.1 C Red-free image 
Imaging of the left retina in an adult rat under the red-free laser. One can see a similar 
shows level of detail to the previous image under infra-red laser, however because the focal 
point of the red-free laser is at the level of the retinal ganglion cell layer, one can see a 
greater delineation of detail of this layer using this laser.  
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4.2 Imaging the retinal nerve fiber layer and determining that the application of 
balanced salt solution and Saran wrap to the cornea was optimal for preservation of 
corneal clarity.  
              
Figure 4.2A 15 minutes                     Figure 4.2B 15 minutes               
OS IR 488 nm laser                    OD IR 488 nm laser  
Control (no Saran)          (Saran removed just prior to image) 
In summary one can see that corneal clarity was better in those rats which had the saran 
wrap applied (images on the right side) compared to those which had not (images on the 
left side) at all time intervals up until 30 minutes.     
 
                
Figure 4.2C 30 minutes           Figure 4.2D (30 minutes) 
OS IR 488 nm laser           OD IR 488 nm laser Saran applied 
(no Saran) at 30 minutes                           and removed just prior to imaging                           
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4.3 Optic nerve transection reduces corneal clarity significantly and therefore 
decreases our ability to visualize the retinal nerve fiber layer  
 
                                     
Figure 4.3A        Figure 4.3B- no fluorescence 
Control OS 48hrs post transection  IR filter          Control OS at 48hrs fluorescein   
       filter 
                                                            
Figure 4.3C       Figure 4.3D- no fluorescence  
Transected right optic nerve day 2                         Right retinal image at 48 hours  
infrared filter.      using the fluorescein filter.    
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4.4 Compare intravitreal injection 0.9%NaCl OD with no intervention OS 
 
Intravitreal injection of sodium chloride did not cause the production of fluorescence.  
 
 
 
Figure 4.4 Red-free (788 nm) image of retina at 15 minutes post intravitreal injection 
on the left and under 488 nm filter on the right clearly demonstrating no fluorescence. 
Similarly there was no fluorescence using the 788 nm filter at any of the time points.  
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HRA2 detection of fluorescent species  
4.5 Quantify the fluorescence of ICG, dihydroethidium and its derivatives using the 
HRA2  
Overall we showed a non-linear reduction in fluorescence intensity as the concentration of 
the fluorescent dyes is reduced.  
 
Oxy-Et Standardisation curves  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4.5 A 
 
 
Calibration curve of Oxy-ET at reducing 
Sensitivites and Serial Dilutions
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Water
1X Oxy ET
0.1 X OxyET
0.01 oxyET
0.001 X oxyET
0.0001oxyET
0.00001 oxyET
0.000001 XoxyET
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Oxy-Et-DNA Standardisation Curves 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4.5 B 
 
 
 
 
 
 
 
 
 
Calibration curve of oxy-ET-DNA
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ICG standardisation curve 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4.5 C 
 
 
 
 
 
 
Calibration Curve of Serial Dilutions of ICG 
from 1x down 
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0.1 X
0.01 X
0.001X
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0.000001X
0.0000001X
0.00000001X
water
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Retrograde labeling of retinal ganglion cells with fluorescent 
markers.  
4.6A HRA2 detection of retinal ganglion cell fluorescent marker indocyanine green 
(ICG)  
 
 
 
 
 
 
 
 
 
 
 
 
 
k 
 
 
 
 
 
 
 
 
 
 
 
  120 hours 
Mean 16.039 
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    © 2007 
Figure 4.6 A1 (left) and A2 
(right)  
Left shows retinal image 
captured using the 30 degree 
field of view at 72 hours.  
 
Right image shows a part of the 
same retinal image at 72 hours 
just lateral to the optic disc but 
this time using the 15 degrees 
field of view. 
Figure 4.6 A4  
Retinal image using 30 degrees field of view at 120 hours.  
Figure 4.6 A3  
Reinal image using 30 degrees field of view captured at 
96 hours. 
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4.7 Examination of fluorescence pattern following injecting the optic nerve with 
Indocyanine green 
Overall there was no significant fluorescence except optic disc autofluorescence which was 
likely to be significant.  
 
           
 
 
 
 
 
 
4.8 Examination of fluorescence pattern following optic nerve injection with DiO  
Overall there was no significant fluorescence except optic disc autofluorescence which was 
likely to be significant.  
 
 
 
 
 
 
 
Figure 4.7 A showing retinal 
image at 24 hours 
24hr Optic Disc fluorescence 
 
48hr Optic Disc fluorescence  
 
72hr No view- no images taken 
 
Day 5 corneal clarity suboptimal- 
hazy view, no fluorescence seen 
 
Day 7 No Fluorescence 
24 hours- no fluorescence 
Day 2 corneal clarity suboptimal 
Day 3 corneal clarity suboptimal 
Day 5 corneal clarity suboptimal 
Day 7 as above 
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4.9 Fluorescein injected intravenously causes fluorescence using the 488 nm laser 
on the HRA2 
Figure 4.9 A 
Red-free prior to injection  
of fluorescein.                            Figure 4.9 B  (fluorescein filter)      Figure 4.9 C   
     
 
    Figure 4.9 D                         Figure 4.9 E                           Figure 4.9 F  
       
Figure 4.9 G      Figure 4.9 H                           Figure 4.9 I      
 \     
   Figure 4.9 J                              Figure 4.9 K                            Figure 4.9 L                 
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Markers of Oxidative Species 
Dihydroethidium and its derivatives 
4.10A Examining for background fluorescence of HEt in the absence of oxidative 
factors in the in vivo model and determining the optimum concentration. 
 
Overall in this experiment we found optimal concentration of HEt was 0.32 mM as higher 
concentrations produce a profound fluorescence and oversaturation and lower 
concentrations produced none. We estimated the specific concentrations to use in this 
experiment by using previous studies as a guide (see introductory chapter).  
 
 
 
 
 
 
 
 
Figures 4.9 A to L: Fluorescein angiogram following intravenous injection of 
fluorescein at a concentration of 2.5g/ml with each image taken at 30 second 
intervals. A used infra-red filter and the remainder of the images used a 
fluorescein filter.  
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Red-free laser on left and fluorescein on right  
Right eye (OD): final intravitreal HEt concentration 3.2 mM 
Left eye (OS):  final intravitreal HEt concentration 0.032 mM 
  
Figure 4.10 A1 Preinjection OD (HEt 3.2 mM) Red-free laser on left and fluorescein 
on right  
                                                                          
Figure 4.10 A2 Preinjection OS (HEt 3.2 mM) Red-free laser on left and fluorescein 
on right   
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Figure 4.10 A3 at 10 minutes post injection OD (3.2 mM HEt). Red-free laser on left 
and fluorescein on right clearly demonstrating speckled fluorescence pattern. This 
speckled fluorescence pattern was continued up until approximately 60 minutes post 
injection and was not present thereafter in the rats which we imaged. We continued to 
repeat the imaging up until 48 hours following the initial intravitreal injection.  
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  \ 
Figure 4.10 A4 at 10 minutes post injection OS (0.032mM HEt). Red-free laser on left 
and fluorescein on right. We continued to repeat the imaging up until 48 hours 
following the initial intravitreal injection and saw no fluorescence on this eye in the 
animals we examined.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 128 
4.10B Demonstrating that HEt does not react with Hydrogen peroxide 
Overall we found that HEt does not react with hydrogen peroxide and produced no 
fluorescence.  
Figure 4.10 B1 showing left eye (control) pre injection with red-free on left and ICG 
on right 
  
Figure 4.10 B2 showing right eye (which had the hydrogen peroxide injected) pre 
injection with red-free on left and ICG on right.  
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Figure 4.10 B3 showing left eye (control) 30 minutes post injection intravenous 
DCFDA with red-free on left and ICG on right.  
 
  
 
 
 
 
Figure 4.10 B4 showing right eye 30 minutes post injection intravenous DCFDA and 
10 minutes following intravitreal injection of hydrogen peroxide with red-free on left 
and ICG on right 
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1.10 C Examination of fluorescence pattern following injection of Ethidium 
Bromide into rats Intravenously  
Overall we found no fluorescence when ethidium bromide was injected intravenously.  
 
Figure 4.10 C1 at 45 mins following ethidium bromide injection intravenously OS 
(Left side shows view under 788 nm filter and right shows view under infrared filter) 
 
Figure 4.10 C2 at 45 mins following ethidium bromide injection intravenously OS 
(Left side shows view under 788 nm filter and right shows view under infrared filter) 
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Menadione  
 
4.11 Examination of fluorescence pattern following intravitreal injection of 
menadione and intravenous injection of HEt.  
No fluorescence was demonstrated at the time points examined.  
 
 
 
Menadione and HEt 
4.12A Examination of fluorescence patterns of mixture of Menadione and HEt when 
both are injected intravitreally 
Overall summary of results demonstrated a speckled pattern of fluorescence but less 
marked in the eye which had both menadione and HEt during first 12 hours,  with an 
absence of this pattern from 24 – 72 hrs.    
Poor clarity was found in both eyes when imaged at day following injection. The results are 
summarized in the below table. Of note there was some fluorescence present prior to 
injection in both eyes in a diffuse pattern making the results difficult to interpret.  
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Time  Action  Result Summary  
 
Day 
1  
3.2 mM HEt 
and 10 mM 
Menadione 
OD with 
HEt 3.2 mM 
HEt OS  
Results (Corneal Clarity excellent): 
 
Time Point OD OS 
Preinjection  Positive 
FA/ ICG 
Positive 
FA/ ICG 
10 Increasing  
above 
Positive 
FA/ ICG 
20 Sustained decreased 
30 Reduced 
both  
Further 
decreased  
45min, 1, 2, 
4, 6 hr 
Reduced  As above 
12 hr Mild 
increase in 
FA 
As above 
 
Speckled 
pattern 
fluorescence 
OU but less OD 
(with 
menadione 
injection)   
 
Reduced as 
time went on 
over  
Day 2  Imaged None OU None at 24hrs 
Day 3  Imaged  None OU None at 48 hrs 
Day 4  Imaged  None OU None at 72 hrs 
Day 5  
 
0.32 mM 
HEt OD and 
0. 032 mM 
OS  
 
Poor clarity  
Increased OS at 10 and 30 mins  
Poor clarity at 45 mins.   
Poor clarity 
  
Table 4.12 A 
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4.12B Examination of fluorescence pattern following intravitreal injection of 
menadione and intravenous injection of Het.  
 
Overall there was mild diffuse fluorescence at all timepoints with no demonstrable pattern.  
 
Table 4.12C 
Time point Imaging Perfomed under both 788 nm and 488 
nm 
 Right Eye                            Left Eye           
0 minutes Mild diffuse fluorescence  Mild diffuse fluorescence  
10  minutes Mild diffuse fluorescence  Mild diffuse fluorescence  
40 minutes Mild diffuse fluorescence  Mild diffuse fluorescence  
50 minutes Mild diffuse fluorescence  Mild diffuse fluorescence  
90 minutes  Mild diffuse fluorescence  Mild diffuse fluorescence  
110 minutes  Mild diffuse fluorescence  Mild diffuse fluorescence  
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4.13 Examination of fluorescence pattern following the injection of ferrous sulfate and 
dihydroethidium intravitreally shows discrete areas of fluorescence.  
 
 
 
 
 
 
 
 
 
 
# 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.13 A 
Examination of retina in the in 
vivo model at 3 days following the 
intravitreal injection of 0.5 mM 
FeSO4 and subsequent injection 
of 0.32 mM dihydroethidium at 45 
minutes prior to the image being 
taken on day 3.  
Figure 4.13 B 
Retinal wholemount following 
removal from the eye. The 
wholemount was held up to the 
HRA2 objective lens on the slide 
and one can see fluorescence on the 
retinal specimen.  
Figure 4.13 C 
Retinal wholemount following removal 
from the eye and examination under 
the axiocam microscope showing 
bright fluorescent areas corresponding 
to the oxidation of dihydroethidium to 
oxyethidium-DNA caused by 
superoxide production.  
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Markers of Oxidative species: DCFDA 
4.14A Determination of optimal intravitreal concentration of DCFDA  
Overall we found the optimal concentration for DCFDA to be 0.32 mM.  
 
4.14B Fluorescence pattern following injection of DCFDA (intravenously) and 
hydrogen peroxide (intravitreally) 
Overall we demonstrated no fluorescence at any of the time points up to and including 100 
minutes. Corneal clarity limited further imaging.  
 
 
4.14C 
To demonstrate that DCFDA and hydrogen peroxide do not react when injected 
intravitreally 
Overall we demonstrated no fluorescence at any of the time points up to and including 70 
minutes. Corneal clarity limited further imaging.  
 
4.14D 
Examination of fluorescence following DCFDA intravenously and Menadione 
intravitreally 
Overall we demonstrated no fluorescence at any of the time points up to and including 80 
minutes. Corneal clarity limited further imaging.  
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Part 2 Retinal ganglion cells after crush  
4.15 Examining the effect of optic nerve crush on retinal ganglion cells labelled with 
ICG 
24 hours following labeling (ICG filter on left and red-free on right) 
Figure 4.15 a     Figure 4.15 b 
  
 
 
 
48 hours following labeling (ICG filter on left and red-free on right) 
Figure 4.15 c                Figure 4.15 d 
  
 
 137 
 
 
 
48 hours following labeling (ICG filter on left and red-free on right) 
Figure 4.15 e                Figure 4.15 f 
  
 
 
72 hours following labeling (ICG filter on left and red-free on right) 
Figure 4.15 g                Figure 4.15 h 
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96 hours following labeling (ICG filter on left and red-free on right) 
Figure 4.15 i                Figure 4.15 j 
  
 
120 hours following labeling (ICG filter on left and red-free on right) 
Figure 4.15 k                            Figure 4.15 
l   
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4.16 Imaging Superoxide Following Optic Nerve Crush using 
CMH2DCFDA 
       Figure 4.16 a                                               Figure 4.16 b 
 
 
 
 
 
 
 
 
 
Above two images showing the side with the crushed optic nerves at 24 hours following 
optic nerve crush. Left side shows the image captured using the red-free filter and image on 
the right shows the image captured using the 488 nm filter. There is no fluorescence visible 
in the latter image unlike the crushed side. We were unable to re-examine the fundi at later 
intervals because of impaired clarity due to cataract formation.  
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Below images (4.16 c and d) showing the control side with the uncrushed optic nerves 
at 24 hours following optic nerve crush. Left side shows the image captured using the red-
free filter and image on the right shows the image captured using the 488 nm filter. There is 
no fluorescence visible in the latter image unlike the crushed side. The experiment was 
repeated three times and yielded the same results.  
 
 
       Figure 4.16 c                                                      Figure 4.16 d 
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4.17 Labeling retinal ganglion cells with ICG and using DCFDA to examine for 
reactive oxygen species following optic nerve crush  
Overall this experiment showed retinal ganglion cells did indeed label with ICG well within 
the first 48 hours however fluorescence rapidly decreased after this. There was no 
fluorescence of oxidative species. I have included all the images so one can appreciate the 
clarity issues encountered.  
 
Figure 4.17 A Right eye preinjection showing red-free (above), 788 nm (below left) 488 
nm (below right)  
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Images taken within the first 24 hours showed no significant changes from the 
initial ones taken. Therefore we are showing those taken at 24 hour intervals 
thereafter.  
Figure 4.17 B Right eye at 24 hours post optic nerve crush showing red-free (above), 
788 nm (below left) 488 nm (below right)  
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Figure 4.17 C Left eye (control) at 24 hours post optic nerve crush showing red-
free (above), 788 nm (below left) 488 nm (below right)  
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Figure 4.17 D Right eye at 48 hours post optic nerve crush showing red-free 
(above), 788 nm (below left).  Image at 488 nm is omitted because of poor corneal 
clarity.  
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Figure 4.17 E Left eye at 48 hours post optic nerve crush of right optic nerve 
showing red-free (above), 788 nm (below left) and 488 nm (below right) with much 
better corneal clarity than the crushed side and therefore much more visible diffuse 
pattern of fluorescence.  
 
 
  
 
 
 
 
 
 
 146 
Figure 4.17 F Right eye at 72 hours post optic nerve crush showing red-free 
(above), 788 nm (below left) 488 nm (below right)  
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Figure 4.17 G Left eye (control) at 72 hours post right optic nerve crush showing 
red-free (above), 788 nm (below left) 488 nm (below right)  
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Chapter 5 Discussion  
Firstly I will give a brief outline of the results in the next few paragraphs. Following this I 
will compare these results to those from other studies and highlight the strengths and 
weaknesses of our study compared with previous work in the same area.  
Our results demonstrated that retinal nerve fiber layer as well as retinal ganglion cells can 
indeed be imaged in the in vivo rat model using the HRA2 apparatus as a convenient and 
alternate method of imaging. We showed that image quality can vary and was highly 
dependant on corneal lubrication, manipulation and duration of each experiment with a 
tendancy to become reduced after 72 hours, optic nerve transection and optic nerve crush. 
Intravitreal injection of normal saline (0.9% sodium chloride) caused no increase in 
fluorescence compared with rats which had no intervention.  
When we standardized the various fluorescent markers, there was a variation in the  
fluorescence of markers at different concentrations (4.5). We showed that retinal ganglion 
cells can be imaged in the in vivo rat model using the retrograde labeling technique of the 
superior colliculus which used ICG as the fluorescent marker. Injecting a fluorescent probe 
into the optic nerve directly did not produce fluorescence. Fluorescein injected 
intravenously did produce fluorescence (4.9). Dihydroethidium did show some background, 
speckled fluorescence in the absence of oxidative stress in the live animal (4.10), although 
of note we were unable to reproduce this in more than one animal. When both 
dihydroethidium and hydrogen peroxide were injected intravitreally, there was no 
fluorescence, which would confirm previous studies which showed that dihydroethidium 
was a more specific marker for superoxide and not hydrogen peroxide (Fink et al 2004, 
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Zhao et al 2003, Zhao et al 2005).  We wanted to demonstrate the fluorescence patterns 
(if any) of the markers of oxidative stress in our study (eg dihydroethidium) when it was 
delivered to the rat model in different ways eg intravenously, intravitreally in order to 
decide on the optimal method of administration. Intravenous injection of eithidium bromide 
(a closely related compound of hydroethidium) showed no fluorescence.  
As already outlined in the introduction and methods, menadione is a known producer of 
oxidative species in the in vitro models. For this reason we wanted to inject it intravitreally 
and examine whether there was fluorescence when dihydroethidium was injected both 
intravenously and intravitreally. We found diffuse fluorescence with intravitreal menadione 
and intravenous dihydroethidium, however it was difficult to ascertain whether this was 
due to diffuse fluorescence because of too high a concentration of the dye.         
As already explained ferrous sulfate dissociates into Fe 2+ causing the formation of 
oxidative species. When ferrous sulfate was injected intravitreally there was a definite 
reproducible pattern of speckled discrete areas of fluorescence.     
When hydrogen peroxide was injected intravitreally we did not show any fluorescence both 
when dihydroethidium was injected intravitreally and intravenously.  
Retinal ganglion cells labeled with ICG whose optic nerve was subsequently crushed 
showed decreasing fluorescence with time. Intravitreal injection of dihydroethidium in rats 
whose optic nerve was crushed showed definite discrete areas of fluorescence at 24 hours 
following optic nerve crush.  In rats whose retinal ganglion cells were simultaneously 
labeled with ICG and crushed, RGCs were identified using ICG but clarity decreased 
dramatically after 24 hours and clarity made any fluorescence from oxidized 
 150 
dihydroethidium very challenging to visualize.    
 
There were many stages involved in the planning and eventual experimental path taken in 
this study. One of these was choosing the appropriate marker for retinal ganglion cells and 
oxidative species. Other groups have outlined the use of ICG, which is a tricarbocyanine 
dye and can be used as a a RGC marker in the rat model using the well-described 
retrograde labeling technique. This dye has an axonal transport rate of 2 mm per hour and 
persistence of this for between 7 to 14 day and its appearance in the RGCs seen within 4 
hours of injection into the lateral geniculate nucleus (Paques et al 2003). These features 
make it an important novel method of marking RGCs and was important in our eventual 
choice of marking agent. Additionally the peak excitation and absorbance is also optimal 
for the 788 nm laser of the HRA2.  
The dialkylcarbocyanines fluorescence is easily detected when incorporated into 
membranes. There are several in existence including DiI, DiO, DiA and DiR (Levin et al 
2006).    It was for this reason that we considered the dialkylcarbocyanines as an alternate 
retinal ganglion cell marker, even injecting one of them (DiO) directly into the optic nerve 
at one point to investigate its potential. This had obvious pitfalls in terms of optic nerve 
damage and therefore was not utilized.  
In an attempt to seek a less invasive method of labeling RGCs, several researchers have 
published techniques using members of the fluorescent protein family to label RGCs. The 
family of fluorescent proteins encompasses several proteins having the distinctive B-
pleated sheet structure of fluorescent proteins. The cell surface glycoprotein known as Thy-
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1 is expressed by projection neurons in many parts of the nervous system and in the 
retina is largely expressed in RGCs. In the transgenic mouse model developed by Feng 
(Feng et al 2000), the fluorescent protein is under the control of the Thy-1 promoter 
construct protein. One paper examined mice in which cyan fluorescent protein was 
expressed in RGCs and used DiI as the confirmatory marker for RGCs. This represented a 
less invasive mechanism for labeling RGCs in the live animal and utilised the confocal 
scanning laser ophthalmoscope to image the RGCs (Leung et al 2008). Another more 
recent paper utilized a similar technique except this time used mice which had yellow 
fluorescent protein expression (Walsh et al 2008). This is a method which could certainly 
be used in future studies   
  
Use of reagents/cell markers which were within the therapeutic/effective range but not 
within the toxic range for live animals was a challenge during the experiments.  
While in the introductory planning of the experiments, we had considered the many 
approaches to labeling retinal ganglion cells in the live animals and the myriad of  
techniques available to label the various oxidative radicals, we did encounter some 
difficulty with regard to using sufficient concentrations of the cell marking agents such as 
indocyanine green to label retinal ganglion cells and dimethsulfoxide (DMSO) as one of 
the diluents of dihydroethidium (Paques et al 2003, Schulman et al 1989). Previous studies 
had reported transient electroretinogram depression after an intravitreal injection of 0.1 ml 
of DMSO at concentrations of 10%, 50% and 100% (Silverman et al 1983). In all of these 
subjects animals had demonstrated a 50% decrease in the amplitude of the scotopic 
response after injection with DMSO one week after the injection. While in our study it 
 152 
would have been technically difficult to perform and confirm absence of 
electroretinogram depression in live rats, we used the minimal concentration of DMSO 
(less than 1.5 %) which had previously not been shown to produce any toxic retinal effects. 
Once we had decided on appropriate labeling agents (e.g. ICG, DiI, HEt etc), we had some 
difficulty getting fluorescence using the 488 nm laser on the HRA2. It was because of this 
that we decided to perform a fluorescein angiogram on an adult rat as described. As 
fluorescein has similar excitation and emission spectra as oxy-ethidium-DNA we were 
therefore able to confirm that this part of our apparatus was indeed functional and 
subsequently were able to demonstrate fluorescence.   
Preserving retinal circulation in the crush technique may have been a factor which made 
our experiment more challenging than expected. While we do not wish to dwell on this, it is 
important to examine this aspect of our study as its correction could dramatically advance 
the progress in imaging retinal ganglion cells. Transection of the optic nerve allows us to 
study the effects of oxidative stress on the retinal ganglion cell, however it also is not 
without its drawbacks. During and following crushing of the optic nerve, we made 
consistent direct visual examination of the retinal vasculature immediately afterwards and 
prior to each imaging session in order to ensure it was preserved. As already outlined in the 
introductary anatomy, the retinal circulation runs along the outside of the optic nerve and 
therefore leaves it prone to injury during crush.  
  
We did have a lot of difficulty with cataract formation and corneal haziness. We attributed 
loss of corneal clarity in many of our animals to either loss of innervation to the cornea 
caused by the crushing mechanism and resultant loss of the corneal blink reflex and the 
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vital mechanisms which maintain corneal hydration and clarity. During our experiment 
we directly observed loss of the blink reflex in animals which developed this problem. This 
was despite our best efforts to mantain clarity by frequent application of lubricants, both 
during and after the experiments. We attributed the cataract formation to an ischemic 
process, probably once again related to crushing of the optic nerve and resultant anterior 
segment ischemic changes in the lens secondary to this. This slowed our progress 
considerably and stimulated us to examine improvements which could be made in technical 
aspects of optic nerve crush surgery, which we outline below.   
Other studies which used a similar imaging modality did not mention corneal clarity as a 
challenge, however this could be related to the fact that these experiments involved much 
less manipulation of the cornea and intraoperative procedures such as intravitreal injections 
etc (Weinreb et al 2008).       
 
A complete transection of the optic nerve will also transect the meningeal sheath. When 
this is done in the rat, then the blood supply to the retina will also be affected. This happens 
because the vessels destined for the retina travel in the meninges, unlike the human central 
retinal artery, which enters the optic nerve within the orbit and continues anteriorly until 
the globe. Strategies to transect the optic nerve within the meningeal sheath have been 
devised, involving making a slit in the sheath and using an instrument to transect the fibers 
within and therefore avoiding damaging the retinal blood suppy and innervation to the 
cornea.  
 
Intravascular injections of reagents using the rats tail veins has been previously examined 
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and literature search of tehnical aspects of this proved helpful and assisted in improving 
delivery techniques (Staszck et al 1993, Philip et al 1997, Kranzlin et al 2001).  
 
Our images which we displayed demonstrated clear images and while this was a challenge 
to achieve, it was possible once technical aspects of our procedures were improved 
(frequent applications of lubricant, improved crushing technique, etc).  While we did 
demonstrate Saran wrap applied to the cornea improved clarity over time periods because 
of improved corneal hydration, imaging through this was difficult and imaging was always 
done with Saran wrap removed.   
Retinal ganglion cells were successfully identified using already established retrograde 
labeling techniques via the superior colliculus and peak fluorescence was achieved at 
between 48 to 72 hours following labelling (see 4.6). Following crush of labelled retinal 
ganglion cells, a decrease in fluorescence was seen from 24 hours onwards. We postulate 
that this was due to decrease in retrograde transport of the labelling dye used after the optic 
nerve wass crushed, although the precise reason underlying this finding remains unknown. 
When we intially started to use the HRA2 apparatus, we had success in labelling with ICG 
and imaging in vivo using the 788 nm laser, however we had difficulty in getting any 
fluorescence when we used the 488 nm laser. We attempted to use this when we labelled 
cells using DiI (a carbocyanine outlined in the introduction, the excitation of which at 488 
nm and emission at 550 nm made it ideal for our experiment). However we consistently 
had difficulty with getting any fluorescence and therefore decided to prove that we could 
image with the 488 nm laser on the HRA2. We did this by performing a fluorescein 
angiogram in which fluorescein is injected intravenously. Fluorescein, outlined in the 
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introductory chapter, is a compound used in human subjects intravenously which 
excites at 488 nm.       
We were able to establish that there was no fluorescence following intravitreal injection of 
normal saline which was used as a diluent in some of our intravitreal injections later on in 
the experiments. This was an important point to establish before proceeding.  
 
In the absence of oxidative species, experiments with intravitreal dihydroethidium showed 
an intense speckled pattern of fluorescence when 3.2 mM dihydroethidium alone was 
injected intravitreally and no fluorescence when 0.032 mM was injected. Therefore we 
used a concentration intermediate between these two values in our experiments to quantify 
reactive oxygen species. We also attempted to investigate whether intravenous delivery of 
one of the oxidation products of dihydroethidium, ethidium, could elicit any fluorescence in 
the absence of oxidative stress. However, no fluorescence was produced. This may have 
been because of inability of the dye to cross into the retinal and/or into retinal cells. 
 
As menadione has already been shown to induces the production of reactive oxygen species 
via redox cycling in other models and ex vivo cultures (Levin et al, 2006), we attempted to 
show this could produce reactive oxygen species in the retina in vivo.  
When both 10 mM menadione and 3.2 mM dihydroethidium were injected intravitreally, a 
similar speckled pattern of fluorescence to the previous experiment was produced. This was  
perhaps not surprising, indicating the concentration of the dihydroethidium was again too 
high. However we failed to elicit any fluorescence even at a 10-fold lower concentration of 
dihydroethidium, indicating that perhaps menadione did not produce sufficient reactive 
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oxygen species to be detected in this in vivo model. 
 
Ferrous sulfate is capable of producing superoxide anion (Rogers et al 2007, Kambayashi 
et al 2003), and therefore its intravitreal injection in experiment 4.13, should have produced 
fluorescence with dihydroethidium. Surprisingly, although we had no fluorescence with in 
vivo imaging, when we did a retinal wholemount (4.13 B) and held the wholemount slide 
up to the HRA2 imaging device, there was fluorescence. When viewed under the 
appropriate filters using a fluorescent microscope, we also had abundant fluorescence in 
multiple discrete patterns, as one would expect from retinal ganglion cells with superoxide 
anion production. The failure to visualise any fluorescence in the live in vivo model despite 
having a clear fundus view (4.13A) may have been because of insufficient intensity, 
although it is difficult to be certain. In view of the many difficulties we had with 
dihydroethidium, i.e. finding an appropriate intravitreal concentration and obtaining no 
fluorescence in the live animal imaging despite having fluorescence in the same retina 
when examined as a wholemout, we decided to use an alternate mechanism to demonstrate 
the production of reactive oxygen species and this was why we then started to use DCFDA.    
     
DCFDA is a nonspecific indicator of reactive oxygen species. As outlined in the 
introductory chapter it fluoresces when exposed to a wide variety of reactive oxygen 
species including superoxide anion. As we found 0.32 mM to be the optimal concentration 
of DCFDA for indicating the production of reactive oxygen species, we proceded to use 
this following optic nerve crush. We noted discrete patterns of fluorescence in the crushed 
optic nerve at 24 hours following crush with no fluoresence produced in the contralateral 
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(control) eye. This indicated the production of reactive oxygen species. DCFDA is a 
nonspecific marker of reactive oxygen species (ROS) and therefore fluoresces when 
multiple ROS subtypes are present. On the contrary dihydroethidium is specific for the 
superoxide anion. One possible reason for why we did not get fluorescence at the same 
time points with dihydroethdium as with DCFDA could be this difference in specificity. 
There also could not be enough superoxide anion produced to elicit sufficient fluorescence 
to be visualized through the ocular media with in vivo imaging. This would explain the 
absence of fluorescence despite clear media. With DCFDA, there may have been several 
reactive oxygen species and presumably a high enough concentration of one or more of 
these to elicit enough fluorescence to be visualized through the ocular media.  
Simultaneously identifying RGCs with ICG while using DCFDA to  image ROS 
production following crush was attempted in 3.15. This had some challenges. Following 
labeling with ICG, the optic nerve in one eye was crushed and unfortunately the intensity of 
ICG fluorescence decreased markedly thereafter making it very difficult to identify any 
specific retinal ganglion cells which produced fluoresence. Despite repeating this several 
times, the multiple surgeries and interventions caused a loss of corneal clarity, hazy 
imaging and difficulty obtaining clear images.        
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Chapter 5 Conclusions 
We conclude that retinal ganglion cells can be identified in vivo using retrograde labeling 
techniques. Reactive oxygen species can be imaged in the in vivo rat model using  
DCFDA, however we were unable to show the production of the superoxide anion using 
HEt as a marker. This may have been due to insufficient production, low sensitivity of 
detection with the filters on the HRA2, or other reasons. Simultaneous labeling of retinal 
ganglion cells and reactive oxygen species was not possible in our model because of issues 
with corneal clarity after optic nerve crush. This may be resolved by future studies where 
the optic nerve is transected but a modified technique is used, e.g. optic nerve sheath 
splitting for optimal preservation of corneal innervation and the retinal vasculature.  
 
Future work should focus on optimal methods of preservation of corneal clarity following 
repeated manipulations (intravitreal injections, imaging, general anesthesia and subsequent 
loss of corneal reflex, optic nerve crush). In addition to this, multiple fluorescent probes for 
several reactive oxygen species could be used in a similar model to image ROS production 
at serial intervals following crushing the optic nerve, including the interesting model 
already shown to work invivo (Leung et al 2008). In this way a better understanding of the 
temporal aspects of ROS production as well as strategies to protect retinal ganglion cells 
from their harmful effects could be addressed.   
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